{"filter":{"health_condition":"other_cancer"},"n_projects":177,"projects":[{"accession":"PRJEB11419","age_categories":{"adolescent":93,"adult":4213,"child":99,"elderly":790,"infant":79,"neonate":1,"unknown":2078},"countries":{"AE":2,"AT":3,"AU":25,"BE":9,"BR":3,"CA":45,"CH":3,"CN":2,"CR":1,"CZ":1,"DE":15,"ES":481,"FM":1,"FR":10,"GB":864,"GE":1,"HK":2,"HR":2,"IE":6,"IT":5,"JE":1,"JP":528,"LV":2,"MD":1,"MN":2,"MX":547,"MY":1,"NL":4,"NO":5,"NZ":1,"PH":86,"PR":1,"RS":3,"SE":1,"TH":6,"US":3501,"ZA":2},"first_public_year":"2015","gbp_per_sample_median":0.12,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":419,"cardiometabolic_other":110,"crohns_disease":7,"gi_infection_or_diarrhoea":26,"healthy_control":241,"ibd_unspecified":46,"ibs":560,"kidney_disease":41,"liver_disease":40,"neurological_psychiatric":379,"other_cancer":218,"other_disease":925,"pregnancy_postpartum":1,"type2_diabetes":91,"ulcerative_colitis":14},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":7353,"papers":[{"doi":"10.1016/j.csbj.2020.08.028","pmcid":"PMC7516180","pmid":"33005310","title":"Multi-population cohort meta-analysis of human intestinal microbiota in early life reveals the existence of infant community state types (ICSTs)."},{"doi":"10.3389/fmolb.2022.949563","pmcid":"PMC9403272","pmid":"36032669","title":"Genomic reconstruction of short-chain fatty acid production by the human gut microbiota."},{"doi":"10.12938/bmfh.2023-043","pmcid":"PMC10767325","pmid":"38188664","title":"Heterogeneity of gut microbiome compositions in the third decade of life in Japanese women: insights from a comparative analysis."},{"doi":"10.1128/msystems.00929-24","pmcid":"PMC11494892","pmid":"39287373","title":"Exploring the vitamin biosynthesis landscape of the human gut microbiota."},{"doi":"10.1128/msystems.00031-18","pmcid":"PMC5954204","pmid":"29795809","title":"American Gut: an Open Platform for Citizen Science Microbiome Research."}],"sample_intervention_arms":{},"sex":{"female":3603,"male":2157},"title":"American Gut Project","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB11419","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB11419_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB11419.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB11419.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB11419.csv.gz"}},{"accession":"PRJNA1235197","age_categories":{"adult":936,"elderly":707,"unknown":8},"countries":{"US":1651},"first_public_year":"2025","gbp_per_sample_median":3.14,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":68,"healthy_control":287,"other_cancer":1294,"other_disease":2},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":1651,"papers":[{"doi":"10.1016/j.cell.2026.09.009","pmcid":null,"pmid":"42810338","title":"Microbiome signatures linked to cancer and treatment adverse events in a real-world cohort."}],"sample_intervention_arms":{},"sex":{"female":905,"male":746},"title":"Microbiome signatures linked to cancer and treatment adverse events in a real-world cohort","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1235197","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1235197_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1235197.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1235197.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1235197.csv.gz"}},{"accession":"PRJNA1391538","age_categories":{"adolescent":199,"adult":18,"child":602,"infant":378,"neonate":45},"countries":{"IT":103,"US":1139},"first_public_year":"2026","gbp_per_sample_median":5.75,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":446,"other_cancer":488,"transplant_or_immunocompromised":308},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":1242,"papers":[{"doi":"10.64898/2026.01.20.26344466","pmcid":null,"pmid":null,"title":"Pre-HCT Resistome Disruption Predicts ESBL Gene Expansion in Pediatric Transplant Recipients: A Prospective Multi-Center Study"}],"sample_intervention_arms":{},"sex":{"female":332,"male":449},"title":"Pre-HCT Resistome Disruption Predicts ESBL Gene Expansion in Pediatric Transplant Recipients: A Prospective Multi-Center Study","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1391538","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1391538_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1391538.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1391538.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1391538.csv.gz"}},{"accession":"PRJNA987980","age_categories":{"adult":322,"elderly":240,"unknown":467},"countries":{"AT":467,"DE":129,"FR":433},"first_public_year":"2024","gbp_per_sample_median":2.99,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_adenoma":115,"healthy_control":186,"other_cancer":261},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":1029,"papers":[{"doi":"10.1099/mgen.0.001330","pmcid":"PMC11728698","pmid":"39804694","title":"Impact of simulation and reference catalogues on the evaluation of taxonomic profiling pipelines."}],"sample_intervention_arms":{},"sex":{"female":223,"male":339},"title":"Microbiome Pipeline Benchmarking","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA987980","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA987980_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA987980.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA987980.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA987980.csv.gz"}},{"accession":"PRJEB64515","age_categories":{"adolescent":6,"adult":351,"child":1,"elderly":292,"unknown":296},"countries":{"PL":946},"first_public_year":"2023","gbp_per_sample_median":0.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":6,"other_cancer":64,"other_disease":206,"other_infection":574,"type1_diabetes":1,"type2_diabetes":95},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":946,"papers":[{"doi":"10.3389/fmicb.2024.1342749","pmcid":"PMC11219902","pmid":"38962119","title":"Gut microbiome dynamics and predictive value in hospitalized COVID-19 patients: a comparative analysis of shallow and deep shotgun sequencing."},{"doi":"10.1093/gigascience/giaf015","pmcid":"PMC11927397","pmid":"40117176","title":"Healthy microbiome-moving towards functional interpretation."}],"sample_intervention_arms":{},"sex":{"female":238,"male":412},"title":"Gut Microbiome Dynamics and Predictive Value in Hospitalized COVID-19 Patients: A Comparative Analysis of Shallow and Deep Shotgun Sequencing","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB64515","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64515_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB64515.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB64515.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64515.csv.gz"}},{"accession":"PRJNA1508239","age_categories":{"child":873},"countries":{"US":873},"first_public_year":"2026","gbp_per_sample_median":0.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":873},"intervention_design":"observational_with_procedure","intervention_detail":"Prospective dietary counseling study during chemotherapy, samples longitudinal","interventions":["other_intervention"],"n_samples":873,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Longitudinal stool metagenomes from children with acute lymphoblastic leukemia during chemotherapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1508239","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1508239_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1508239.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1508239.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1508239.csv.gz"}},{"accession":"PRJNA1023304","age_categories":{"unknown":655},"countries":{"US":471},"first_public_year":"2024","gbp_per_sample_median":1.56,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":9,"other_cancer":81},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":655,"papers":[{"doi":"10.1038/s41591-025-03957-4","pmcid":"PMC12618227","pmid":"41238915","title":"Microbial signals in primary and metastatic brain tumors."},{"doi":"10.1016/j.ccell.2026.06.004","pmcid":"PMC13479879","pmid":"42349430","title":"Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth."}],"sample_intervention_arms":{},"sex":{},"title":"Microbial landscape of primary and metastatic brain tumors","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1023304","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1023304_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1023304.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1023304.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1023304.csv.gz"}},{"accession":"PRJDB4176","age_categories":{"adult":375,"elderly":270},"countries":{"JP":645},"first_public_year":"2019","gbp_per_sample_median":6.49,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_adenoma":72,"colorectal_cancer":258,"healthy_control":247,"other_cancer":40},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":645,"papers":[{"doi":"10.1186/s12866-021-02153-x","pmcid":"PMC8011136","pmid":"33789570","title":"Bacterial community structure alterations within the colorectal cancer gut microbiome."},{"doi":"10.7717/peerj.21488","pmcid":"PMC13378470","pmid":"42491728","title":"Clinical strains isolated from early-stage colorectal cancer patients promote tumorigenesis."},{"doi":"10.1038/s41588-026-02692-x","pmcid":"PMC13553305","pmid":"42576026","title":"Prevalence and chronology of colibactin-associated mutational processes and their microbiome spectra in Japanese colorectal cancer."},{"doi":"10.1186/s12864-020-6749-z","pmcid":"PMC7216530","pmid":"32393180","title":"Host DNA contents in fecal metagenomics as a biomarker for intestinal diseases and effective treatment."},{"doi":"10.1038/s41598-021-82449-0","pmcid":"PMC7854710","pmid":"33531651","title":"Bacterial associations in the healthy human gut microbiome across populations."}],"sample_intervention_arms":{},"sex":{"female":263,"male":360},"title":"metagenomic data from human fecal samples","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB4176","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB4176_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB4176.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB4176.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB4176.csv.gz"}},{"accession":"PRJNA832909","age_categories":{"adult":228,"elderly":332},"countries":{"JP":278},"first_public_year":"2022","gbp_per_sample_median":1.16,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":470,"other_cancer":90},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":560,"papers":[{"doi":"10.1053/j.gastro.2022.03.054","pmcid":null,"pmid":"35398347","title":"Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study."},{"doi":"10.17305/bb.2023.9934","pmcid":"PMC11293218","pmid":"38153528","title":"Oral microbiome-driven virulence factors: A novel approach to pancreatic cancer diagnosis."},{"doi":"10.1371/journal.pone.0302361","pmcid":"PMC11060577","pmid":"38687802","title":"Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer."},{"doi":"10.1101/2024.10.02.616338","pmcid":null,"pmid":null,"title":"Genderized Gut and Oral Microbiome Shifts: Uncovering Sex-Specific Dysbiosis in Pancreatic Cancer"},{"doi":"10.1038/s41467-024-54797-8","pmcid":"PMC11603027","pmid":"39604394","title":"Multi-biome analysis identifies distinct gut microbial signatures and their crosstalk in ulcerative colitis and Crohn's disease."}],"sample_intervention_arms":{},"sex":{"female":252,"male":308},"title":"Metagenomics of the fecal and salivary microbiome of pancreatic cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA832909","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA832909_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA832909.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA832909.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA832909.csv.gz"}},{"accession":"PRJNA1023797","age_categories":{"adult":242,"elderly":257},"countries":{"FR":499},"first_public_year":"2024","gbp_per_sample_median":3.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":499},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":499,"papers":[{"doi":"10.1038/s41522-025-00827-2","pmcid":"PMC12475161","pmid":"41006325","title":"Intestinal fungal signatures and their impact on immune checkpoint inhibitor efficacy: a multi-cohort meta-analysis."},{"doi":"10.1186/s40168-025-02273-w","pmcid":"PMC12781464","pmid":"41345980","title":"Deciphering the personalized functional redundancy hierarchy in the gut microbiome."},{"doi":"10.1002/advs.202520095","pmcid":"PMC13334858","pmid":"41972457","title":"A Microbial Lipid-ATP Synthase Axis Fuels NK Cell Antitumor Activity."}],"sample_intervention_arms":{},"sex":{},"title":"Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1023797","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1023797_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1023797.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1023797.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1023797.csv.gz"}},{"accession":"PRJDB20360","age_categories":{"unknown":490},"countries":{"JP":490},"first_public_year":"2025","gbp_per_sample_median":6.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":490,"papers":[{"doi":"10.1038/s41598-026-47830-x","pmcid":"PMC13230625","pmid":"41963512","title":"Metabolic and functional pathways of gut microbiota in patients with gastric cancer."}],"sample_intervention_arms":{},"sex":{},"title":"JACCRO GC-18","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB20360","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB20360_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB20360.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB20360.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB20360.csv.gz"}},{"accession":"PRJNA1116523","age_categories":{"adult":231,"elderly":156},"countries":{"PL":387},"first_public_year":"2024","gbp_per_sample_median":3.72,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":121,"other_cancer":150,"other_disease":116},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":387,"papers":[{"doi":"10.3390/ijms25158026","pmcid":"PMC11311272","pmid":"39125593","title":"Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients."}],"sample_intervention_arms":{},"sex":{"female":138,"male":117},"title":"Microbial and metabolic gut profiling across seven malignancies identifies fecal Faecalibacillus intestinalis and formic acid as commonly altered in cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1116523","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1116523_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1116523.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1116523.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1116523.csv.gz"}},{"accession":"PRJEB91718","age_categories":{"adult":365,"elderly":18},"countries":{"PL":383},"first_public_year":"2025","gbp_per_sample_median":10.05,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":1,"healthy_control":141,"other_cancer":24,"other_disease":73,"other_infection":97,"type2_diabetes":47},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":383,"papers":[{"doi":"10.3389/fmicb.2024.1342749","pmcid":"PMC11219902","pmid":"38962119","title":"Gut microbiome dynamics and predictive value in hospitalized COVID-19 patients: a comparative analysis of shallow and deep shotgun sequencing."}],"sample_intervention_arms":{},"sex":{"female":95,"male":147},"title":"COVID-19 Microbiome - deep samples","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB91718","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB91718_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB91718.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB91718.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB91718.csv.gz"}},{"accession":"PRJNA1042925","age_categories":{"unknown":375},"countries":{"CN":375},"first_public_year":"2025","gbp_per_sample_median":12.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":375},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":375,"papers":[{"doi":"10.1016/j.xcrm.2023.101355","pmcid":"PMC10829783","pmid":"38194971","title":"Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy."},{"doi":"10.1016/j.xcrm.2026.103009","pmcid":"PMC13589492","pmid":"42664954","title":"Lactobacillus salivarius potentiates gastrointestinal cancer immunotherapy through its metabolite chenodeoxycholic acid."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal samples of microsatellite instability-high cancer patients Raw sequence reads","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1042925","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1042925_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1042925.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1042925.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1042925.csv.gz"}},{"accession":"PRJEB54704","age_categories":{"adult":174,"elderly":177},"countries":{"DE":229,"US":122},"first_public_year":"2023","gbp_per_sample_median":0.07,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":351},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":351,"papers":[{"doi":"10.1038/s41591-023-02234-6","pmcid":"PMC10121864","pmid":"36914893","title":"A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy."},{"doi":"10.1182/blood.2024025366","pmcid":"PMC12782970","pmid":"39441941","title":"Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy."},{"doi":"10.3390/microorganisms13112595","pmcid":"PMC12654497","pmid":"41304278","title":"Multi-Kingdom Gut Microbiome Interaction Characteristics Predict Immune Checkpoint Inhibitor Efficacy Across Pan-Cancer Cohorts."}],"sample_intervention_arms":{},"sex":{"female":97,"male":254},"title":"Gut microbiome associations with clinical outcomes of CD19-targeted CAR-T cell immunotherapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB54704","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB54704_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB54704.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB54704.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB54704.csv.gz"}},{"accession":"PRJNA751792","age_categories":{"adult":163,"elderly":175},"countries":{"FR":338},"first_public_year":"2021","gbp_per_sample_median":3.25,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"neurological_psychiatric":161,"other_cancer":177},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":338,"papers":[{"doi":"10.1038/s41591-021-01655-5","pmcid":"PMC9330544","pmid":"35115705","title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer."},{"doi":"10.1186/s12967-026-07900-0","pmcid":"PMC13041121","pmid":"41749306","title":"Distinct gut virome profiles are associated with response to anti-PD-1 therapy in non-small cell lung cancer."},{"doi":"10.20517/mrr.2025.117","pmcid":"PMC13091084","pmid":"42007374","title":"A responder-informed gut microbial consortium enhances anti-PD-1 efficacy in a mouse cancer model."},{"doi":"10.1038/s41467-023-42997-7","pmcid":"PMC10654443","pmid":"37973916","title":"Gut microbial structural variation associates with immune checkpoint inhibitor response."},{"doi":"10.20517/mrr.2024.09","pmcid":"PMC11480726","pmid":"39421249","title":"Pangenomic analysis identifies correlations between <i>Akkermansia</i> species and subspecies and human health outcomes."}],"sample_intervention_arms":{},"sex":{"female":112,"male":226},"title":"Intestinal Akkermansia muciniphila predicts clinical response to PD1 blockade in advanced non-small cell lung cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA751792","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA751792_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA751792.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA751792.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA751792.csv.gz"}},{"accession":"PRJNA1503619","age_categories":{"adult":308},"countries":{"CA":308},"first_public_year":"2026","gbp_per_sample_median":6.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":308,"papers":[{"doi":"10.64898/2026.02.06.26345778","pmcid":null,"pmid":null,"title":"Gut microbiome and metabolome reveal hormone-related and functional alterations in ER-positive breast cancer: a case–control study"}],"sample_intervention_arms":{},"sex":{},"title":"Gut Microbiome and Breast Cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1503619","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1503619_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1503619.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1503619.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1503619.csv.gz"}},{"accession":"PRJEB63351","age_categories":{"infant":85,"neonate":1,"unknown":202},"countries":{"IT":288},"first_public_year":"2023","gbp_per_sample_median":7.05,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":225,"other_cancer":63},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":288,"papers":[{"doi":"10.1016/j.ebiom.2023.104917","pmcid":"PMC10731604","pmid":"38104504","title":"Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal microbial seeding."}],"sample_intervention_arms":{},"sex":{"female":198,"male":90},"title":"Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal seeding","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB63351","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB63351_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB63351.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB63351.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB63351.csv.gz"}},{"accession":"PRJNA1265886","age_categories":{"adult":283},"countries":{},"first_public_year":"2025","gbp_per_sample_median":2.51,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":283},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":283,"papers":[{"doi":"10.1038/s41522-025-00725-7","pmcid":"PMC12106833","pmid":"40419513","title":"Distal gut colonization by oral bacteria during intensive chemotherapy: direct evidence from strain-level analysis of paired samples."}],"sample_intervention_arms":{},"sex":{},"title":"Longitudinal oral and gut microbiota profiling in AML patients undergoing intensive chemotherapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1265886","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1265886_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1265886.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1265886.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1265886.csv.gz"}},{"accession":"PRJNA1241852","age_categories":{"unknown":282},"countries":{"US":282},"first_public_year":"2026","gbp_per_sample_median":7.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":282},"intervention_design":"randomized_controlled_trial","intervention_detail":"Dietary intervention in melanoma patients, incl. immunotherapy recipients","interventions":["diet_intervention"],"n_samples":282,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"dietary intervention trial in patients with melanoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1241852","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1241852_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1241852.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1241852.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1241852.csv.gz"}},{"accession":"PRJNA1295573","age_categories":{"adult":204,"elderly":74},"countries":{"US":278},"first_public_year":"2026","gbp_per_sample_median":11.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":278},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":278,"papers":[{"doi":"10.1038/s41523-026-00922-3","pmcid":"PMC13066469","pmid":"41760690","title":"The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)."}],"sample_intervention_arms":{},"sex":{"female":278},"title":"The intestinal microbiome of patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1295573","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1295573_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1295573.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1295573.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1295573.csv.gz"}},{"accession":"PRJEB94043","age_categories":{"adult":255},"countries":{"IT":255},"first_public_year":"2025","gbp_per_sample_median":11.92,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":255},"intervention_design":"randomized_controlled_trial","intervention_detail":"Donor FMT vs placebo FMT plus pembrolizumab and axitinib","interventions":["drug_therapy","fmt"],"n_samples":255,"papers":[{"doi":"10.1038/s41591-025-04189-2","pmcid":"PMC13099650","pmid":"41606119","title":"Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial."}],"sample_intervention_arms":{},"sex":{},"title":"Clinical trial (TACITO) for the evaluation of the efficacy of targeted of fecal microbiota transplantation (FMT) in improving response rates to immune checkpoint inhibitors (ICIs) in subjects with treatment-naïve metastatic renal cell carcinoma.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB94043","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB94043_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB94043.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB94043.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB94043.csv.gz"}},{"accession":"PRJNA716780","age_categories":{"adolescent":8,"adult":85,"child":29,"infant":88,"neonate":1,"unknown":43},"countries":{"IT":254},"first_public_year":"2022","gbp_per_sample_median":7.35,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":152,"other_disease":69},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":254,"papers":[{"doi":"10.1038/s41586-022-05620-1","pmcid":"PMC9892008","pmid":"36653448","title":"The person-to-person transmission landscape of the gut and oral microbiomes."},{"doi":"10.1016/j.cub.2023.04.011","pmcid":"PMC10234599","pmid":"37116481","title":"Maternal and food microbial sources shape the infant microbiome of a rural Ethiopian population."},{"doi":"10.1038/s41467-024-51398-3","pmcid":"PMC11322291","pmid":"39138199","title":"Insights into the ecology of the infant gut plasmidome."},{"doi":"10.1038/s42003-026-09639-2","pmcid":"PMC12963580","pmid":"41620544","title":"Gut microbial signatures expose the westernized lifestyle of urban Ethiopian children."}],"sample_intervention_arms":{},"sex":{"female":175,"male":79},"title":"Mothers/children Metagenome","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA716780","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA716780_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA716780.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA716780.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA716780.csv.gz"}},{"accession":"PRJNA421352","age_categories":{"adolescent":38,"adult":1,"child":144,"infant":63},"countries":{"US":246},"first_public_year":"2017","gbp_per_sample_median":0.01,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":30,"other_cancer":216},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":246,"papers":[{"doi":"10.1038/s41598-025-27280-7","pmcid":"PMC12675574","pmid":"41339392","title":"Distinct functional and compositional properties in the gut microbiome of children with acute lymphoblastic leukaemia identified by shotgun metagenomics."}],"sample_intervention_arms":{},"sex":{"female":89,"male":157},"title":"Gut microbiome in Children with Acute Lymphoblastic Leukemia (ALL)","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA421352","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA421352_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA421352.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA421352.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA421352.csv.gz"}},{"accession":"PRJEB38625","age_categories":{"adult":157,"elderly":87},"countries":{"ES":244},"first_public_year":"2022","gbp_per_sample_median":1.84,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"allergy_or_atopy":1,"healthy_control":33,"obesity":8,"other_cancer":25,"other_disease":8,"type2_diabetes":2},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":244,"papers":[{"doi":"10.1136/gutjnl-2021-324755","pmcid":"PMC9185815","pmid":"35260444","title":"A faecal microbiota signature with high specificity for pancreatic cancer."},{"doi":"10.1016/j.isci.2024.109294","pmcid":"PMC10915599","pmid":"38450156","title":"Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut microbiome and exposome data."},{"doi":"10.1097/js9.0000000000001762","pmcid":"PMC11487005","pmid":"38874485","title":"The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing."},{"doi":"10.1016/j.cpblue.2026.100034","pmcid":"PMC13269251","pmid":"42312244","title":"Strain transmission links human microbiomes along the oral-gut axis and across cohabiting individuals."}],"sample_intervention_arms":{},"sex":{"female":49,"male":87},"title":"The oral and fecal microbiome in chronic pancreatitis and pancreatic cancer.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB38625","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38625_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB38625.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB38625.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB38625.csv.gz"}},{"accession":"PRJNA943135","age_categories":{"unknown":244},"countries":{"PL":244},"first_public_year":"2023","gbp_per_sample_median":4.2,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":38,"ibd_unspecified":43,"other_cancer":118},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":244,"papers":[{"doi":"10.3389/fcimb.2023.1190910","pmcid":"PMC10413277","pmid":"37577378","title":"Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection."}],"sample_intervention_arms":{},"sex":{},"title":"A diarrhoeal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is further impacted by Clostridioides difficile infection.","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA943135","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA943135_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA943135.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA943135.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA943135.csv.gz"}},{"accession":"PRJEB70966","age_categories":{"adult":232},"countries":{"NL":232},"first_public_year":"2024","gbp_per_sample_median":3.96,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":232},"intervention_design":"observational_with_procedure","intervention_detail":"Immune checkpoint blockade (anti-PD-1) therapy for advanced melanoma","interventions":["drug_therapy"],"n_samples":232,"papers":[{"doi":"10.1038/s41591-024-02803-3","pmcid":"PMC10957474","pmid":"38365950","title":"Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma."},{"doi":"10.1016/j.chom.2024.10.006","pmcid":"PMC11629153","pmid":"39481388","title":"Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients."}],"sample_intervention_arms":{},"sex":{},"title":"Longitudinal gut microbiome changes in immune checkpoint blockade in advanced melanoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB70966","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB70966_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB70966.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB70966.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB70966.csv.gz"}},{"accession":"PRJEB50408","age_categories":{"adult":221,"neonate":1},"countries":{"US":222},"first_public_year":"2022","gbp_per_sample_median":1.15,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"allergy_or_atopy":21,"healthy_control":136,"neurological_psychiatric":10,"other_cancer":15,"other_disease":30,"other_infection":10},"intervention_design":"randomized_controlled_trial","intervention_detail":"Resistant starch blend (potato, banana, apple fiber) vs potato starch control, escalating doses","interventions":["prebiotic_or_fibre"],"n_samples":222,"papers":[{"doi":"10.3389/fnut.2022.987216","pmcid":"PMC9559413","pmid":"36245486","title":"The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps."},{"doi":"10.1038/s41587-023-01696-w","pmcid":"PMC10504420","pmid":"36928429","title":"Contamination source modeling with SCRuB improves cancer phenotype prediction from microbiome data."}],"sample_intervention_arms":{},"sex":{"female":149,"male":47},"title":"Resistant starch gut microbiome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB50408","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB50408_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB50408.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB50408.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB50408.csv.gz"}},{"accession":"PRJEB22863","age_categories":{"adult":125,"elderly":94},"countries":{"FR":219},"first_public_year":"2017","gbp_per_sample_median":2.99,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":219},"intervention_design":"observational_with_procedure","intervention_detail":"Anti-PD-1 therapy; FMT and A. muciniphila supplementation in mouse models","interventions":["drug_therapy","fmt","probiotic"],"n_samples":219,"papers":[{"doi":"10.1126/science.aan3706","pmcid":null,"pmid":"29097494","title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors."},{"doi":"10.3389/fonc.2022.837525","pmcid":"PMC9069064","pmid":"35530307","title":"Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients."},{"doi":"10.1186/s12967-025-06370-0","pmcid":"PMC11916936","pmid":"40098172","title":"Prioritizing gut microbial SNPs linked to immunotherapy outcomes in NSCLC patients by integrative bioinformatics analysis."},{"doi":"10.1126/sciadv.aaz2299","pmcid":"PMC7176420","pmid":"32494636","title":"Metagenomic growth rate inferences of strains in situ."},{"doi":"10.1084/jem.20200606","pmcid":"PMC7664509","pmid":"33175106","title":"Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers."}],"sample_intervention_arms":{"drug_therapy":92,"no_intervention":127},"sex":{"female":47,"male":127},"title":"Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB22863","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB22863_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB22863.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB22863.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB22863.csv.gz"}},{"accession":"PRJNA1289847","age_categories":{"adult":216},"countries":{"CA":216},"first_public_year":"2025","gbp_per_sample_median":8.03,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":89},"intervention_design":"single_arm_before_after","intervention_detail":"Healthy donor FMT (oral capsules) plus anti-PD-1 ± anti-CTLA-4","interventions":["drug_therapy","fmt"],"n_samples":216,"papers":[{"doi":"10.1038/s41591-025-04186-5","pmcid":"PMC13099432","pmid":"41606121","title":"Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial."}],"sample_intervention_arms":{"fmt":214},"sex":{"female":5,"male":28},"title":"Gut microbiota composition of patients in FMT-LUMINate clinical trial","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1289847","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1289847_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1289847.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1289847.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1289847.csv.gz"}},{"accession":"PRJNA672867","age_categories":{"adult":134,"elderly":82},"countries":{"US":216},"first_public_year":"2020","gbp_per_sample_median":2.19,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":216},"intervention_design":"single_arm_before_after","intervention_detail":"Responder-derived FMT combined with anti-PD-1 therapy in refractory melanoma","interventions":["drug_therapy","fmt"],"n_samples":216,"papers":[{"doi":"10.1126/science.abf3363","pmcid":"PMC8097968","pmid":"33542131","title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients."},{"doi":"10.1371/journal.pone.0274633","pmcid":"PMC9477264","pmid":"36107983","title":"Time series strain tracking analysis post fecal transplantation identifies individual specific patterns of fecal dominant donor, recipient, and unrelated microbial strains."},{"doi":"10.1186/s12866-021-02312-0","pmcid":"PMC8454007","pmid":"34544375","title":"Incongruence between dominant commensal donor microbes in recipient feces post fecal transplant and response to anti-PD-1 immunotherapy."},{"doi":"10.1126/science.aaz7015","pmcid":"PMC8970537","pmid":"34941392","title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response."},{"doi":"10.1126/sciimmunol.abn0704","pmcid":"PMC9925043","pmid":"36083892","title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer."}],"sample_intervention_arms":{"fmt":167,"no_intervention":49},"sex":{"female":65,"male":151},"title":"Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA672867","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA672867_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA672867.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA672867.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA672867.csv.gz"}},{"accession":"PRJNA1268044","age_categories":{"unknown":210},"countries":{"KR":210},"first_public_year":"2025","gbp_per_sample_median":11.14,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":210},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":210,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome data from patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) in Korea","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1268044","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1268044_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1268044.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1268044.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1268044.csv.gz"}},{"accession":"PRJNA1453174","age_categories":{"adult":146,"elderly":54},"countries":{"KE":200},"first_public_year":"2026","gbp_per_sample_median":7.39,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":113,"other_disease":87},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":200,"papers":[],"sample_intervention_arms":{},"sex":{"female":92,"male":108},"title":"Gut microbiome of subjects with either gastric cancer or gastritis","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1453174","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1453174_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1453174.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1453174.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1453174.csv.gz"}},{"accession":"PRJEB6070","age_categories":{"adult":116,"elderly":83},"countries":{"DE":43,"FR":156},"first_public_year":"2014","gbp_per_sample_median":5.24,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_adenoma":42,"healthy_control":66,"other_cancer":91},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":199,"papers":[{"doi":"10.1038/s41467-019-08844-4","pmcid":"PMC6399450","pmid":"30833550","title":"Microbial abundance, activity and population genomic profiling with mOTUs2."},{"doi":"10.7717/peerj.7315","pmcid":"PMC6673421","pmid":"31392094","title":"Association network analysis identifies enzymatic components of gut microbiota that significantly differ between colorectal cancer patients and healthy controls."},{"doi":"10.1093/bioinformatics/btz686","pmcid":null,"pmid":"31504188","title":"Phylogenetic tree-based microbiome association test."},{"doi":"10.1073/pnas.1912129116","pmcid":"PMC6883805","pmid":"31712445","title":"Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures."},{"doi":"10.3892/ol.2020.11967","pmcid":"PMC7439112","pmid":"32831925","title":"Alteration of the abundance of Parvimonas micra in the gut along the adenoma-carcinoma sequence."}],"sample_intervention_arms":{},"sex":{"female":82,"male":117},"title":"Potential of fecal microbiota for early stage detection of colorectal cancer","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB6070","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB6070_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB6070.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB6070.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB6070.csv.gz"}},{"accession":"PRJNA1190411","age_categories":{"adult":198},"countries":{"US":198},"first_public_year":"2024","gbp_per_sample_median":11.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":198,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Dietary fiber intake and gut microbial fiber fermentation capacity are associated with favorable clinical outcomes following immune checkpoint blockade","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1190411","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1190411_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1190411.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1190411.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1190411.csv.gz"}},{"accession":"PRJNA1372070","age_categories":{"unknown":197},"countries":{"CN":197},"first_public_year":"2026","gbp_per_sample_median":7.24,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":196},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":197,"papers":[{"doi":"10.1002/imt2.70123","pmcid":"PMC13147943","pmid":"42099457","title":"Two stable gut microbiome guilds predict liver tumor class and treatment responses."}],"sample_intervention_arms":{},"sex":{},"title":"Hepatocellular Carcinoma Cohort Metagenomics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1372070","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1372070_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1372070.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1372070.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1372070.csv.gz"}},{"accession":"PRJNA1314234","age_categories":{"unknown":194},"countries":{"CA":194},"first_public_year":"2025","gbp_per_sample_median":3.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from ir-colitis patient into antibiotic-pretreated tumor-bearing mice","interventions":["antibiotic","fmt"],"n_samples":194,"papers":[{"doi":"10.1186/s40168-026-02419-4","pmcid":"PMC13288583","pmid":"42083059","title":"Metagenomics and culturomics reveal the dual role of the gut microbiome in the development of immune-related toxicities and the efficacy of immune checkpoint inhibitors in cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Human and mouse gut microbiome sequencing datasets related to immune checkpoint inhibitor therapy and immune-related adverse events.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1314234","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1314234_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1314234.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1314234.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1314234.csv.gz"}},{"accession":"PRJDB41979","age_categories":{"adult":183},"countries":{"CN":183},"first_public_year":"2026","gbp_per_sample_median":7.94,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":183},"intervention_design":"randomized_controlled_trial","intervention_detail":"Bifidobacterium animalis subsp. lactis V9 probiotic vs placebo during chemotherapy","interventions":["probiotic"],"n_samples":183,"papers":[{"doi":"10.1093/ismeco/ycag127","pmcid":"PMC13362969","pmid":"42445733","title":"Bifidobacterium animalis subsp. lactis V9 improves quality of life in advanced gastrointestinal cancer through gut microbiota-metabolite modulation."}],"sample_intervention_arms":{},"sex":{},"title":"Bifidobacterium animalis subsp. lactis V9 Improves Quality of Life in Advanced Gastrointestinal Cancer Through Gut Microbiota-Metabolite Modulation (PRJCA053988)","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB41979","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB41979_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB41979.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB41979.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB41979.csv.gz"}},{"accession":"PRJNA389927","age_categories":{"adult":58,"elderly":19,"unknown":104},"countries":{"CA":57,"US":124},"first_public_year":"2017","gbp_per_sample_median":0.63,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_adenoma":56,"healthy_control":69,"other_cancer":56},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":181,"papers":[{"doi":"10.1128/mbio.02248-18","pmcid":"PMC6247079","pmid":"30459201","title":"Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome."},{"doi":"10.1128/mbio.01454-19","pmcid":"PMC6606814","pmid":"31266879","title":"Fecal Short-Chain Fatty Acids Are Not Predictive of Colonic Tumor Status and Cannot Be Predicted Based on Bacterial Community Structure."},{"doi":"10.1186/s13059-024-03236-4","pmcid":"PMC11020464","pmid":"38622738","title":"Benchmarking bioinformatic virus identification tools using real-world metagenomic data across biomes."},{"doi":"10.1038/s41467-021-23265-y","pmcid":"PMC8144394","pmid":"34031391","title":"Identification of microbial markers across populations in early detection of colorectal cancer."},{"doi":"10.3389/fmicb.2021.765291","pmcid":"PMC8715872","pmid":"34975790","title":"Species-Level Analysis of the Human Gut Microbiome Shows Antibiotic Resistance Genes Associated With Colorectal Cancer."}],"sample_intervention_arms":{},"sex":{"female":35,"male":46},"title":"Viral and Bacterial Communities of Colorectal Cancer","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA389927","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA389927_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA389927.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA389927.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA389927.csv.gz"}},{"accession":"PRJNA1282887","age_categories":{"unknown":176},"countries":{"CN":176},"first_public_year":"2025","gbp_per_sample_median":0.24,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":176},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":176,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Multi-Site Microbiome Profiling Reveals Gastrointestinal-Pulmonary Microbial Associations in Multiple Primary Lung Cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1282887","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1282887_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1282887.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1282887.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1282887.csv.gz"}},{"accession":"PRJNA1093257","age_categories":{"unknown":175},"countries":{"KR":175},"first_public_year":"2024","gbp_per_sample_median":10.49,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":175},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":175,"papers":[{"doi":"10.1007/s00253-026-13948-1","pmcid":"PMC13631169","pmid":"42417977","title":"Metagenomics comparison identifies shared pathogenic microbiome in humans, pigs and chickens."}],"sample_intervention_arms":{},"sex":{},"title":"Matched shotgun sequencing data from bladder cancer patients","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1093257","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1093257_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1093257.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1093257.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1093257.csv.gz"}},{"accession":"PRJEB110936","age_categories":{"adult":51,"elderly":123},"countries":{"KR":174},"first_public_year":"2026","gbp_per_sample_median":10.49,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":174},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":174,"papers":[],"sample_intervention_arms":{},"sex":{"female":32,"male":142},"title":"Comparative Analysis of Urinary, Bladder Tissue, and Stool Microbiota in Bladder Cancer Using Shotgun Metagenomics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB110936","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB110936_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB110936.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB110936.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB110936.csv.gz"}},{"accession":"PRJEB66197","age_categories":{"adult":173},"countries":{"NL":173},"first_public_year":"2023","gbp_per_sample_median":5.62,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":173},"intervention_design":"randomized_controlled_trial","intervention_detail":"Autologous natural dendritic cell injections vs placebo, adjuvant","interventions":["vaccine"],"n_samples":173,"papers":[{"doi":"10.1038/s41467-024-45357-1","pmcid":"PMC10891084","pmid":"38395948","title":"Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial."},{"doi":"10.21203/rs.3.rs-4294379/v1","pmcid":null,"pmid":null,"title":"Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines"}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB66197","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB66197_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB66197.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB66197.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB66197.csv.gz"}},{"accession":"PRJNA770295","age_categories":{"adult":83,"elderly":84},"countries":{"US":167},"first_public_year":"2021","gbp_per_sample_median":2.62,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":167},"intervention_design":"observational_with_procedure","intervention_detail":"Observed dietary fiber/probiotic use; preclinical low-fiber diet/probiotic feeding in mice","interventions":["diet_intervention","probiotic"],"n_samples":167,"papers":[{"doi":"10.1126/science.aaz7015","pmcid":"PMC8970537","pmid":"34941392","title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response."},{"doi":"10.1128/msystems.01023-22","pmcid":"PMC10134792","pmid":"36809182","title":"Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy."},{"doi":"10.1038/s41467-023-42997-7","pmcid":"PMC10654443","pmid":"37973916","title":"Gut microbial structural variation associates with immune checkpoint inhibitor response."},{"doi":"10.1038/s41591-024-02803-3","pmcid":"PMC10957474","pmid":"38365950","title":"Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma."},{"doi":"10.26508/lsa.202302480","pmcid":"PMC10917649","pmid":"38448159","title":"Systemic metabolic depletion of gut microbiome undermines responsiveness to melanoma immunotherapy."}],"sample_intervention_arms":{},"sex":{"female":58,"male":109},"title":"Dietary fiber and probiotics impact the gut microbiome and melanoma immunotherapy response","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA770295","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA770295_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA770295.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA770295.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA770295.csv.gz"}},{"accession":"PRJDB18316","age_categories":{"unknown":166},"countries":{"JP":166},"first_public_year":"2024","gbp_per_sample_median":11.94,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":60,"other_cancer":106},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":166,"papers":[{"doi":"10.3389/fcimb.2026.1754671","pmcid":"PMC12876203","pmid":"41660426","title":"SSTDhunter: a curated gene database for investigating androgen producing potential in microbiota species."}],"sample_intervention_arms":{},"sex":{},"title":"Association between polygenic risk score for prostate cancer and the gut microbiota","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB18316","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB18316_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB18316.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB18316.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB18316.csv.gz"}},{"accession":"PRJEB43119","age_categories":{"adolescent":1,"adult":67,"elderly":95,"unknown":2},"countries":{"ES":12,"GB":98,"NL":55},"first_public_year":"2021","gbp_per_sample_median":6.2,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":165},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":165,"papers":[{"doi":"10.1016/j.xcrm.2026.102921","pmcid":"PMC13400165","pmid":"42447866","title":"Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth."},{"doi":"10.1038/s41591-022-01695-5","pmcid":"PMC8938272","pmid":"35228751","title":"Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma."},{"doi":"10.1128/msystems.01023-22","pmcid":"PMC10134792","pmid":"36809182","title":"Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy."},{"doi":"10.1038/s41467-023-42997-7","pmcid":"PMC10654443","pmid":"37973916","title":"Gut microbial structural variation associates with immune checkpoint inhibitor response."},{"doi":"10.1038/s41591-024-02803-3","pmcid":"PMC10957474","pmid":"38365950","title":"Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma."}],"sample_intervention_arms":{},"sex":{"female":65,"male":100},"title":"Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB43119","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB43119_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB43119.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB43119.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB43119.csv.gz"}},{"accession":"PRJEB28058","age_categories":{"adult":164},"countries":{"DE":164},"first_public_year":"2019","gbp_per_sample_median":11.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":164},"intervention_design":"unknown","intervention_detail":"Cotrimoxazole or ciprofloxacin prophylactic antibiotic, samples before/after treatment","interventions":["antibiotic"],"n_samples":164,"papers":[{"doi":"10.1186/s12915-019-0692-y","pmcid":"PMC6749691","pmid":"31533707","title":"Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study."},{"doi":"10.1186/s40168-023-01604-z","pmcid":"PMC10408196","pmid":"37553697","title":"Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions."}],"sample_intervention_arms":{},"sex":{},"title":"Impact of antibiotics on the human gut microbiome and resistome","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB28058","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28058_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB28058.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB28058.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28058.csv.gz"}},{"accession":"PRJNA972625","age_categories":{"adult":119,"elderly":45},"countries":{"PL":164},"first_public_year":"2024","gbp_per_sample_median":2.46,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":164,"papers":[{"doi":"10.1007/s00262-024-03918-9","pmcid":"PMC11861499","pmid":"39998665","title":"Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy."},{"doi":"10.1158/2326-6066.cir-23-0592","pmcid":"PMC10985481","pmid":"38315788","title":"Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy."}],"sample_intervention_arms":{},"sex":{"female":33,"male":60},"title":"Changes in gut mycobiome in Polish melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA972625","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA972625_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA972625.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA972625.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA972625.csv.gz"}},{"accession":"PRJNA1430386","age_categories":{"unknown":163},"countries":{"CA":160,"US":3},"first_public_year":"2026","gbp_per_sample_median":3.89,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"colorectal_cancer":7,"crohns_disease":16,"neurological_psychiatric":11,"other_cancer":41,"other_disease":22},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":163,"papers":[],"sample_intervention_arms":{"drug_therapy":35,"no_intervention":43},"sex":{"female":20,"male":55},"title":"Impact of bladder microbiome on BCG response","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1430386","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1430386_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1430386.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1430386.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1430386.csv.gz"}},{"accession":"PRJEB91542","age_categories":{"adult":159},"countries":{"NL":159},"first_public_year":"2025","gbp_per_sample_median":6.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"colorectal_cancer":68,"other_cancer":91},"intervention_design":"observational_with_procedure","intervention_detail":"Nivolumab immune checkpoint blockade therapy","interventions":["drug_therapy"],"n_samples":159,"papers":[{"doi":"10.1158/2159-8290.cd-24-1669","pmcid":null,"pmid":"40996449","title":"Microbial Metabolic Pathways Guide Response to Immune Checkpoint Blockade Therapy."}],"sample_intervention_arms":{"drug_therapy":77,"no_intervention":82},"sex":{"female":57,"male":41},"title":"Microbial metabolic pathways guide response to immune checkpoint blockade therapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB91542","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB91542_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB91542.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB91542.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB91542.csv.gz"}},{"accession":"PRJNA787952","age_categories":{"adolescent":41,"adult":51,"child":54,"unknown":9},"countries":{"US":155},"first_public_year":"2022","gbp_per_sample_median":4.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":98,"other_disease":51,"transplant_or_immunocompromised":6},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral vancomycin-polymyxin B gut decontamination vs no-GD in allo-HCT patients","interventions":["antibiotic"],"n_samples":155,"papers":[{"doi":"10.1172/jci.insight.154344","pmcid":"PMC9057614","pmid":"35239511","title":"Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation."},{"doi":"10.1101/2021.12.16.21267940","pmcid":null,"pmid":null,"title":"Randomized controlled trial of gut decontamination in pediatric patients undergoing allogeneic hematopoietic cell transplantation"}],"sample_intervention_arms":{},"sex":{},"title":"Raw_metagenomic_sequencing_for_Pediatrics_Gut_Decontamination_NCT02641236","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA787952","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA787952_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA787952.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA787952.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA787952.csv.gz"}},{"accession":"PRJEB97759","age_categories":{"adult":154},"countries":{"CN":154},"first_public_year":"2025","gbp_per_sample_median":3.92,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":154,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Multi-kingdom gut microbiome for gastric cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB97759","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB97759_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB97759.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB97759.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB97759.csv.gz"}},{"accession":"PRJNA1001944","age_categories":{"adult":122,"elderly":31},"countries":{"PL":153},"first_public_year":"2024","gbp_per_sample_median":3.79,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":3,"healthy_control":10,"ibs":51,"other_cancer":80},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":153,"papers":[{"doi":"10.3389/fonc.2024.1279132","pmcid":"PMC10848918","pmid":"38327745","title":"Breast cancer but not the menopausal status is associated with small changes of the gut microbiota."},{"doi":"10.3390/ijms25158026","pmcid":"PMC11311272","pmid":"39125593","title":"Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients."}],"sample_intervention_arms":{},"sex":{"female":153},"title":"Breast cancer but not the menopausal status is associated with small changes of the gut microbiota","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1001944","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1001944_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1001944.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1001944.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1001944.csv.gz"}},{"accession":"PRJNA1142892","age_categories":{"elderly":148},"countries":{"US":148},"first_public_year":"2025","gbp_per_sample_median":1.53,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":63,"neurological_psychiatric":36,"other_cancer":49},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":148,"papers":[{"doi":"10.1007/s11357-025-01917-x","pmcid":"PMC13575041","pmid":"41175312","title":"Gut microbiome signatures predict cognitive impairment in older cancer survivors."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiome modulators in the prevention and mitigation of accelerated aging biology caused by cancer treatment","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1142892","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1142892_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1142892.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1142892.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1142892.csv.gz"}},{"accession":"PRJNA1195614","age_categories":{"unknown":148},"countries":{"CN":148},"first_public_year":"2025","gbp_per_sample_median":2.84,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":148,"papers":[{"doi":"10.1016/j.virs.2026.08.010","pmcid":"PMC13556328","pmid":"42586263","title":"Blood and gut virome remodeling in gastric cancer: Anellovirus expansion and novel virus discovery."}],"sample_intervention_arms":{},"sex":{},"title":"blood, upper respiratory tract, and gut metagenome","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1195614","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1195614_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1195614.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1195614.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1195614.csv.gz"}},{"accession":"PRJNA656820","age_categories":{"child":148},"countries":{"US":148},"first_public_year":"2021","gbp_per_sample_median":0.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":148},"intervention_design":"non_randomized_controlled","intervention_detail":"Levofloxacin antibiotic prophylaxis vs no prophylaxis during leukaemia induction","interventions":["antibiotic"],"n_samples":148,"papers":[{"doi":"10.1016/s2666-5247(20)30202-0","pmcid":"PMC8336918","pmid":"34355208","title":"Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis."}],"sample_intervention_arms":{},"sex":{},"title":"Human stool sequencing","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA656820","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA656820_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA656820.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA656820.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA656820.csv.gz"}},{"accession":"PRJEB72821","age_categories":{"adult":146},"countries":{"GB":146},"first_public_year":"2025","gbp_per_sample_median":2.62,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":146},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":146,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"EMBRACER_metagenomics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB72821","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB72821_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB72821.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB72821.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB72821.csv.gz"}},{"accession":"PRJEB65987","age_categories":{"unknown":140},"countries":{"NL":140},"first_public_year":"2024","gbp_per_sample_median":0.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":62,"other_cancer":4,"transplant_or_immunocompromised":74},"intervention_design":"observational_with_procedure","intervention_detail":"Intra-duodenal immunoglobulin treatment for chronic norovirus infection, observational","interventions":[],"n_samples":140,"papers":[{"doi":"10.1016/j.ebiom.2024.105391","pmcid":"PMC11663770","pmid":"39396425","title":"Patterns of the within-host evolution of human norovirus in immunocompromised individuals and implications for treatment."}],"sample_intervention_arms":{},"sex":{},"title":"Intra-host evolution of Norovirus in immunocompromised individuals","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB65987","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB65987_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB65987.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB65987.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB65987.csv.gz"}},{"accession":"PRJNA1129514","age_categories":{"unknown":139},"countries":{"US":139},"first_public_year":"2025","gbp_per_sample_median":10.39,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":139},"intervention_design":"observational_with_procedure","intervention_detail":"Prophylactic/empirical antibiotics during AML induction chemotherapy","interventions":["antibiotic"],"n_samples":139,"papers":[{"doi":"10.3390/antibiotics14080770","pmcid":"PMC12382674","pmid":"40867965","title":"Characterization of Antibiotic Administration Factors Associated with Microbiome Disruption and Subsequent Antibiotic-Resistant Infection and Colonization Events in Acute Myeloid Leukemia Patients Rec"},{"doi":"10.3389/fcimb.2025.1629422","pmcid":"PMC12408608","pmid":"40918253","title":"Utilization of machine learning to predict antibiotic resistant event outcomes in acute myeloid leukemia patients undergoing induction chemotherapy."},{"doi":"10.1080/29933935.2025.2570502","pmcid":"PMC12940128","pmid":"41909910","title":"Gut microbiome features and resistome elements associated with colonization and infection with antibiotic-resistance threats."}],"sample_intervention_arms":{},"sex":{},"title":"Shotgun metagenomics for PA13 AML patients Raw sequence reads Raw sequence reads","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1129514","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1129514_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1129514.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1129514.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1129514.csv.gz"}},{"accession":"PRJNA453965","age_categories":{"unknown":133},"countries":{"CN":133},"first_public_year":"2018","gbp_per_sample_median":22.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":133},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":133,"papers":[{"doi":"10.1016/j.heliyon.2024.e37422","pmcid":"PMC11417245","pmid":"39315152","title":"MBCN: A novel reference database for Effcient Metagenomic analysis of human gut microbiome."},{"doi":"10.1186/s12967-025-07513-z","pmcid":"PMC12817542","pmid":"41390654","title":"Metagenomic analyses reveal E. coli-derived siderophores as potential signatures for breast cancer."},{"doi":"10.3389/fmicb.2025.1722632","pmcid":"PMC12853649","pmid":"41623622","title":"Gut microbial and functional signatures in breast cancer: an integrated metagenomic and machine learning approach to non-invasive detection."},{"doi":"10.1128/msystems.00455-22","pmcid":"PMC9426597","pmid":"35736002","title":"Identification and Characterization of Major Bile Acid 7α-Dehydroxylating Bacteria in the Human Gut."},{"doi":"10.1093/nar/gkaf1205","pmcid":"PMC12807719","pmid":"41359024","title":"gutMSNP: a comprehensive database for human gut microbial single-nucleotide polymorphisms."}],"sample_intervention_arms":{},"sex":{"female":133},"title":"Studies of human gut metagenome Metagenome in breast cancer patients.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA453965","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA453965_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA453965.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA453965.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA453965.csv.gz"}},{"accession":"PRJNA727667","age_categories":{"unknown":120},"countries":{"CN":120},"first_public_year":"2024","gbp_per_sample_median":23.8,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":120,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Human lung cancer metagenomic raw sequence reads","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA727667","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA727667_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA727667.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA727667.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA727667.csv.gz"}},{"accession":"PRJNA932948","age_categories":{"adult":120},"countries":{"TH":120},"first_public_year":"2023","gbp_per_sample_median":5.18,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":76,"liver_disease":25,"other_cancer":19},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":120,"papers":[{"doi":"10.1038/s41598-023-38307-2","pmcid":"PMC10349051","pmid":"37452065","title":"Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma."},{"doi":"10.1038/s41522-026-00921-z","pmcid":"PMC12966491","pmid":"41605932","title":"Modeling diet-gut microbiome interactions and prebiotic responses in Thai adults."},{"doi":"10.1002/imt2.70123","pmcid":"PMC13147943","pmid":"42099457","title":"Two stable gut microbiome guilds predict liver tumor class and treatment responses."}],"sample_intervention_arms":{},"sex":{"female":22,"male":98},"title":"Dysbiosys of the gut microbiota in Thai hepatocellular carcinoma and intrahepatic cholangiocarcinoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA932948","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA932948_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA932948.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA932948.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA932948.csv.gz"}},{"accession":"PRJNA1107274","age_categories":{"adult":65,"elderly":48},"countries":{"US":113},"first_public_year":"2024","gbp_per_sample_median":7.24,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":113},"intervention_design":"single_arm_before_after","intervention_detail":"Neoadjuvant TLR9 agonist vidutolimod plus anti-PD-1 nivolumab","interventions":["drug_therapy"],"n_samples":113,"papers":[{"doi":"10.1016/j.ccell.2024.10.007","pmcid":"PMC11560503","pmid":"39486411","title":"Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial."}],"sample_intervention_arms":{"drug_therapy":87,"no_intervention":26},"sex":{"female":45,"male":68},"title":"Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1107274","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1107274_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1107274.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1107274.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1107274.csv.gz"}},{"accession":"PRJNA1290813","age_categories":{"adult":113},"countries":{"CA":113},"first_public_year":"2025","gbp_per_sample_median":15.12,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":113},"intervention_design":"single_arm_before_after","intervention_detail":"Encapsulated donor FMT plus ICI therapy (ipilimumab/nivolumab or pembrolizumab combos)","interventions":["drug_therapy","fmt"],"n_samples":113,"papers":[{"doi":"10.1038/s41591-025-04183-8","pmcid":"PMC13099417","pmid":"41606120","title":"Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial."}],"sample_intervention_arms":{},"sex":{},"title":"FMT plus systemic therapy in renal cell cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1290813","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1290813_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1290813.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1290813.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1290813.csv.gz"}},{"accession":"PRJNA928211","age_categories":{"adult":69,"elderly":39},"countries":{"KR":108},"first_public_year":"2023","gbp_per_sample_median":2.04,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":108},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":108,"papers":[{"doi":"10.4143/crt.2024.675","pmcid":"PMC12016819","pmid":"39164084","title":"Clinical Impact of Microbiome Characteristics in Treatment-Naïve Extranodal NK/T-Cell Lymphoma Patients."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome of DLBCL patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA928211","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA928211_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA928211.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA928211.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA928211.csv.gz"}},{"accession":"PRJEB49516","age_categories":{"adult":68,"elderly":39},"countries":{"AU":107},"first_public_year":"2024","gbp_per_sample_median":6.15,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":107},"intervention_design":"single_arm_before_after","intervention_detail":"Combination ipilimumab and nivolumab immune checkpoint blockade in rare cancers","interventions":["drug_therapy"],"n_samples":107,"papers":[{"doi":"10.1038/s41591-024-02823-z","pmcid":"PMC10957475","pmid":"38429524","title":"A gut microbial signature for combination immune checkpoint blockade across cancer types."},{"doi":"10.1016/j.isci.2025.112162","pmcid":"PMC11937697","pmid":"40151642","title":"Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types."},{"doi":"10.1002/advs.202520095","pmcid":"PMC13334858","pmid":"41972457","title":"A Microbial Lipid-ATP Synthase Axis Fuels NK Cell Antitumor Activity."},{"doi":"10.1080/19490976.2026.2662690","pmcid":"PMC13114121","pmid":"42026803","title":"Gene-level gut microbiome signatures as predictive biomarkers for response to immune checkpoint inhibitors across multiple cancer types."},{"doi":"10.34133/csbj.0065","pmcid":"PMC13173278","pmid":"42146906","title":"Ecological and Functional Stratification of the Stool Microbiome Predicts Response to Immune Checkpoint Inhibitors across Cancer Types."}],"sample_intervention_arms":{},"sex":{"female":68,"male":36},"title":"Role_of_microbiome_in_rare_cancers_in_Australia","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB49516","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB49516_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB49516.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB49516.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB49516.csv.gz"}},{"accession":"PRJNA906201","age_categories":{"unknown":107},"countries":{"CN":107},"first_public_year":"2023","gbp_per_sample_median":11.31,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":64},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":107,"papers":[{"doi":"10.3390/microorganisms11030546","pmcid":"PMC10059697","pmid":"36985120","title":"Association Studies on Gut and Lung Microbiomes in Patients with Lung Adenocarcinoma."},{"doi":"10.3389/frmbi.2025.1589686","pmcid":"PMC12993565","pmid":"41852386","title":"Microbial hallmarks of the respiratory tract in lung cancer: a meta-analysis."}],"sample_intervention_arms":{},"sex":{},"title":"The gut and lung microbiomes in lung adenocarcinoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA906201","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA906201_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA906201.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA906201.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA906201.csv.gz"}},{"accession":"PRJNA918651","age_categories":{"adult":59,"elderly":44},"countries":{"US":103},"first_public_year":"2023","gbp_per_sample_median":0.77,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":103},"intervention_design":"randomized_controlled_trial","intervention_detail":"Mediterranean diet counseling vs USDA diet, 15 weeks","interventions":["diet_intervention"],"n_samples":103,"papers":[{"doi":"10.1128/mbio.02308-23","pmcid":"PMC10746218","pmid":"37877698","title":"Characterizing the microbiome of patients with myeloproliferative neoplasms during a Mediterranean diet intervention."},{"doi":"10.1158/2767-9764.crc-23-0380","pmcid":"PMC10913729","pmid":"38391189","title":"The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence."}],"sample_intervention_arms":{},"sex":{"female":72,"male":28},"title":"Characterizing the microbiome of patients with myeloproliferative neoplasms during a Mediterranean diet intervention","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA918651","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA918651_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA918651.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA918651.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA918651.csv.gz"}},{"accession":"PRJNA978931","age_categories":{"adult":101},"countries":{"US":101},"first_public_year":"2024","gbp_per_sample_median":21.61,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":101},"intervention_design":"randomized_controlled_trial","intervention_detail":"SER-401 spore formulation + vancomycin preconditioning + nivolumab vs placebo, melanoma","interventions":["antibiotic","drug_therapy","live_biotherapeutic"],"n_samples":101,"papers":[{"doi":"10.1158/2159-8290.cd-24-0066","pmcid":"PMC11215408","pmid":"38588588","title":"Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiome intervention with SER-401 prior to nivolumab for unresectable or metastatic melanoma: a randomized placebo-controlled, biomarker-stratified multicenter phase 1b trial","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA978931","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA978931_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA978931.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA978931.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA978931.csv.gz"}},{"accession":"PRJNA1096686","age_categories":{"adult":53,"elderly":43},"countries":{"US":96},"first_public_year":"2024","gbp_per_sample_median":0.64,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":6,"crohns_disease":16,"healthy_control":12,"ibd_unspecified":3,"neurological_psychiatric":36,"other_cancer":10,"other_disease":1,"type2_diabetes":3,"ulcerative_colitis":5},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":96,"papers":[{"doi":"10.1038/s41531-025-00894-4","pmcid":"PMC11923181","pmid":"40108151","title":"Comparative analysis of Parkinson's and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion."}],"sample_intervention_arms":{},"sex":{"female":47,"male":49},"title":"A comparative analysis of Parkinson's disease, inflammatory bowel disease, and control gut microbiomes with shotgun metagenomics","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1096686","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1096686_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1096686.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1096686.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1096686.csv.gz"}},{"accession":"PRJNA910239","age_categories":{"adult":95},"countries":{"CN":95},"first_public_year":"2023","gbp_per_sample_median":12.21,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":95},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":95,"papers":[{"doi":"10.3389/fcimb.2023.1099063","pmcid":"PMC10084768","pmid":"37051296","title":"Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors."}],"sample_intervention_arms":{},"sex":{},"title":"fecal samples metagenomics data from patients with irAEs","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA910239","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA910239_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA910239.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA910239.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA910239.csv.gz"}},{"accession":"PRJNA762360","age_categories":{"adult":28,"elderly":66},"countries":{"US":94},"first_public_year":"2022","gbp_per_sample_median":8.9,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":65,"other_disease":29},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":94,"papers":[{"doi":"10.1136/jitc-2026-015617","pmcid":"PMC13384208","pmid":"42463281","title":"<i>Blautia coccoides</i>-derived acetate potentiates anti-PD-1 immunotherapy in melanoma by activating cytotoxic CD8<sup>+</sup> T cells."},{"doi":"10.1038/s41591-022-01698-2","pmcid":"PMC10246505","pmid":"35228752","title":"Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1."},{"doi":"10.18632/oncotarget.28252","pmcid":"PMC9295706","pmid":"35875611","title":"Predicting cancer immunotherapy response from gut microbiomes using machine learning models."},{"doi":"10.1126/sciimmunol.abn0704","pmcid":"PMC9925043","pmid":"36083892","title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer."},{"doi":"10.1038/s41467-023-42997-7","pmcid":"PMC10654443","pmid":"37973916","title":"Gut microbial structural variation associates with immune checkpoint inhibitor response."}],"sample_intervention_arms":{"drug_therapy":67,"no_intervention":27},"sex":{"female":28,"male":66},"title":"Intestinal Microbiota Signatures Predict Clinical Outcome and Immune-related Adverse Events in PD-1 Treated Melanoma Patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA762360","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA762360_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA762360.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA762360.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA762360.csv.gz"}},{"accession":"PRJEB59450","age_categories":{"adult":51,"elderly":42},"countries":{"DE":93},"first_public_year":"2023","gbp_per_sample_median":0.07,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":4,"cardiometabolic_other":15,"crohns_disease":41,"neurological_psychiatric":2,"other_cancer":1,"other_disease":30},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":93,"papers":[{"doi":"10.1093/bjs/znad129","pmcid":null,"pmid":"37260059","title":"Whole 16S rRNA sequencing of the oral microbiome predicts postoperative pancreatic fistula: prospective observational cohort study."}],"sample_intervention_arms":{},"sex":{"female":25,"male":37},"title":"PDA-MAPS - Pancreatic Ductal Adenocarcinoma - Microbiome As Predictor of Subtypes - Fistula","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB59450","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB59450_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB59450.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB59450.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB59450.csv.gz"}},{"accession":"PRJNA1365475","age_categories":{"adult":91},"countries":{"IN":91},"first_public_year":"2025","gbp_per_sample_median":0.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":91},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":91,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Gut Microbiome and Immunotherapy in Advanced Non-Small Cell Lung Cancer: A Prospective Cohort Study","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1365475","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1365475_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1365475.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1365475.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1365475.csv.gz"}},{"accession":"PRJNA715586","age_categories":{"adult":90},"countries":{"FR":90},"first_public_year":"2021","gbp_per_sample_median":4.47,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":90},"intervention_design":"single_arm_before_after","intervention_detail":"Autologous FMT after intensive chemotherapy and antibiotics in AML","interventions":["fmt"],"n_samples":90,"papers":[{"doi":"10.1038/s41467-021-23376-6","pmcid":"PMC8149453","pmid":"34035290","title":"Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients."}],"sample_intervention_arms":{},"sex":{},"title":"PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (ODYSSEE)","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA715586","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA715586_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA715586.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA715586.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA715586.csv.gz"}},{"accession":"PRJNA1229669","age_categories":{"adult":64,"elderly":25},"countries":{"KR":89},"first_public_year":"2025","gbp_per_sample_median":10.64,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":89},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":89,"papers":[{"doi":"10.1182/bloodadvances.2025016858","pmcid":"PMC12955626","pmid":"41364878","title":"Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome shotgun metagenome data from DLBCL patients receiving CAR-T therapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1229669","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1229669_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1229669.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1229669.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1229669.csv.gz"}},{"accession":"PRJNA1291832","age_categories":{"adult":33,"elderly":54},"countries":{"AU":87},"first_public_year":"2025","gbp_per_sample_median":7.33,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":87},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":87,"papers":[],"sample_intervention_arms":{"drug_therapy":48,"no_intervention":39},"sex":{"female":36,"male":51},"title":"Shotgun metagenomics data of melanoma patients undergoing ICB","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1291832","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1291832_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1291832.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1291832.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1291832.csv.gz"}},{"accession":"PRJNA811494","age_categories":{"adult":42,"elderly":41,"neonate":3},"countries":{"HU":86},"first_public_year":"2023","gbp_per_sample_median":7.77,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":86},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":86,"papers":[{"doi":"10.1038/s41467-023-38058-8","pmcid":"PMC10169812","pmid":"37160893","title":"Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions."},{"doi":"10.1038/s41598-026-47296-x","pmcid":"PMC13319499","pmid":"42062386","title":"The gut mycobiome and inter-kingdom microbial networks are linked to COPD severity in lung cancer patients."},{"doi":"10.21203/rs.3.rs-7992928/v1","pmcid":null,"pmid":null,"title":"The Gut Mycobiome and Inter-kingdom Microbial Networks are linked to COPD Severity in Lung Cancer Patients"}],"sample_intervention_arms":{},"sex":{"female":34,"male":52},"title":"ITS2 and whole metagenomics from stool of human lung cancer patients from hungary","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA811494","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA811494_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA811494.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA811494.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA811494.csv.gz"}},{"accession":"PRJNA1031550","age_categories":{"adult":82},"countries":{"CN":82},"first_public_year":"2025","gbp_per_sample_median":10.95,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":18,"other_cancer":64},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":82,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Study of fecal microbiota different in human between patients with intracranial tumor and healthy controls","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1031550","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1031550_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1031550.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1031550.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1031550.csv.gz"}},{"accession":"PRJNA791751","age_categories":{"adult":17,"elderly":61},"countries":{"FR":78},"first_public_year":"2022","gbp_per_sample_median":7.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":78},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":78,"papers":[{"doi":"10.1136/jitc-2021-004191","pmcid":"PMC8928383","pmid":"35296557","title":"Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer."}],"sample_intervention_arms":{},"sex":{"male":78},"title":"Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA791751","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA791751_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA791751.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA791751.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA791751.csv.gz"}},{"accession":"PRJEB42013","age_categories":{"adult":41,"elderly":35},"countries":{"DE":76},"first_public_year":"2022","gbp_per_sample_median":5.84,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":31,"other_cancer":45},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":76,"papers":[{"doi":"10.1128/msystems.01229-24","pmcid":"PMC11915875","pmid":"40013793","title":"Association of tumor microbiome with survival in resected early-stage PDAC."},{"doi":"10.1136/gutjnl-2021-324755","pmcid":"PMC9185815","pmid":"35260444","title":"A faecal microbiota signature with high specificity for pancreatic cancer."},{"doi":"10.1016/j.isci.2024.109294","pmcid":"PMC10915599","pmid":"38450156","title":"Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut microbiome and exposome data."},{"doi":"10.1097/js9.0000000000001762","pmcid":"PMC11487005","pmid":"38874485","title":"The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing."},{"doi":"10.1016/j.cpblue.2026.100034","pmcid":"PMC13269251","pmid":"42312244","title":"Strain transmission links human microbiomes along the oral-gut axis and across cohabiting individuals."}],"sample_intervention_arms":{},"sex":{"female":42,"male":34},"title":"Non-invasive, robust and specific fecal microbiota-based screening for the early detection of PDAC.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB42013","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB42013_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB42013.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB42013.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB42013.csv.gz"}},{"accession":"PRJNA749645","age_categories":{"adult":18,"elderly":55,"neonate":1},"countries":{"CH":29,"GB":45},"first_public_year":"2021","gbp_per_sample_median":2.96,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":74},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":74,"papers":[{"doi":"10.1093/nargab/lqag110","pmcid":"PMC13551040","pmid":"42712939","title":"Identifying fundamental gaps in functional metagenomics: a step towards unlocking microbiome research potential."},{"doi":"10.3389/fcimb.2026.1754671","pmcid":"PMC12876203","pmid":"41660426","title":"SSTDhunter: a curated gene database for investigating androgen producing potential in microbiota species."}],"sample_intervention_arms":{},"sex":{"male":74},"title":"Whole genome metagenome of gut microbiota from prostate cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA749645","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA749645_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA749645.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA749645.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA749645.csv.gz"}},{"accession":"PRJNA1062109","age_categories":{"adult":73},"countries":{"FR":73},"first_public_year":"2025","gbp_per_sample_median":10.99,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":73},"intervention_design":"single_arm_before_after","intervention_detail":"MaaT033 pooled fecal microbiotherapy capsules after chemotherapy, phase 1b","interventions":["live_biotherapeutic"],"n_samples":73,"papers":[{"doi":"10.1182/bloodadvances.2024015571","pmcid":"PMC12305571","pmid":"40197991","title":"Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase 1b CIMON trial."}],"sample_intervention_arms":{},"sex":{},"title":"Safety and Tolerability Evaluation of MaaT033 (CIMON)","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1062109","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1062109_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1062109.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1062109.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1062109.csv.gz"}},{"accession":"PRJNA1128111","age_categories":{"adult":73},"countries":{"US":73},"first_public_year":"2025","gbp_per_sample_median":12.02,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":73,"papers":[{"doi":"10.3390/antibiotics14080770","pmcid":"PMC12382674","pmid":"40867965","title":"Characterization of Antibiotic Administration Factors Associated with Microbiome Disruption and Subsequent Antibiotic-Resistant Infection and Colonization Events in Acute Myeloid Leukemia Patients Rec"},{"doi":"10.3389/fcimb.2025.1629422","pmcid":"PMC12408608","pmid":"40918253","title":"Utilization of machine learning to predict antibiotic resistant event outcomes in acute myeloid leukemia patients undergoing induction chemotherapy."},{"doi":"10.1080/29933935.2025.2570502","pmcid":"PMC12940128","pmid":"41909910","title":"Gut microbiome features and resistome elements associated with colonization and infection with antibiotic-resistance threats."}],"sample_intervention_arms":{},"sex":{},"title":"Shotgun metagenomics for PA15 AML patients Raw sequence reads","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1128111","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1128111_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1128111.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1128111.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1128111.csv.gz"}},{"accession":"PRJEB123871","age_categories":{"adult":56,"elderly":15},"countries":{},"first_public_year":"2026","gbp_per_sample_median":2.13,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":11,"other_cancer":60},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":71,"papers":[{"doi":"10.1111/ejh.70121","pmcid":"PMC13050679","pmid":"41582602","title":"Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing."}],"sample_intervention_arms":{},"sex":{"female":31,"male":40},"title":"Microbiome‐Based Modeling of CAR‐T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB123871","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB123871_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB123871.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB123871.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB123871.csv.gz"}},{"accession":"PRJNA494824","age_categories":{"adult":68,"elderly":3},"countries":{"US":71},"first_public_year":"2019","gbp_per_sample_median":7.14,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":12,"other_cancer":59},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":71,"papers":[{"doi":"10.1186/s40168-020-00811-2","pmcid":"PMC7059390","pmid":"32138779","title":"Predictable modulation of cancer treatment outcomes by the gut microbiota."},{"doi":"10.1002/advs.202411052","pmcid":"PMC12245021","pmid":"40285661","title":"β-Glucuronidase-Expressing Lactobacillus reuteri Triggers Irinotecan Enterotoxicity Through Depleting the Regenerative Epithelial Stem/Progenitor Pool."},{"doi":"10.1002/cam4.6503","pmcid":"PMC10557844","pmid":"37676050","title":"Identification of microbial markers associated with lung cancer based on multi-cohort 16 s rRNA analyses: A systematic review and meta-analysis."},{"doi":"10.3389/fcimb.2025.1591076","pmcid":"PMC12336193","pmid":"40792105","title":"Exploring fecal microbiota signatures associated with immune response and antibiotic impact in NSCLC: insights from metagenomic and machine learning approaches."},{"doi":"10.34133/csbj.0065","pmcid":"PMC13173278","pmid":"42146906","title":"Ecological and Functional Stratification of the Stool Microbiome Predicts Response to Immune Checkpoint Inhibitors across Cancer Types."}],"sample_intervention_arms":{"drug_therapy":23},"sex":{"female":40,"male":31},"title":"Gut metagenomic raw sequence reads of cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA494824","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA494824_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA494824.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA494824.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA494824.csv.gz"}},{"accession":"PRJNA928744","age_categories":{"adult":27,"elderly":44},"countries":{"CA":71},"first_public_year":"2023","gbp_per_sample_median":5.2,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":11,"other_cancer":60},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from healthy donor combined with anti-PD1 therapy in melanoma","interventions":["drug_therapy","fmt"],"n_samples":71,"papers":[{"doi":"10.1136/jitc-2025-012659","pmcid":"PMC12359429","pmid":"40759441","title":"Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial."},{"doi":"10.1016/j.chom.2024.10.006","pmcid":"PMC11629153","pmid":"39481388","title":"Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients."},{"doi":"10.1038/s41586-025-09249-8","pmcid":"PMC12390848","pmid":"40659786","title":"Microbiota-driven antitumour immunity mediated by dendritic cell migration."},{"doi":"10.1186/s40168-025-02249-w","pmcid":"PMC12590682","pmid":"41199348","title":"Accurate profiling of microbial communities for shotgun metagenomic sequencing with Meteor2."},{"doi":"10.34133/csbj.0065","pmcid":"PMC13173278","pmid":"42146906","title":"Ecological and Functional Stratification of the Stool Microbiome Predicts Response to Immune Checkpoint Inhibitors across Cancer Types."}],"sample_intervention_arms":{},"sex":{"female":20,"male":40},"title":"Gut microbiota composition of patients in MIMic cohort","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA928744","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA928744_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA928744.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA928744.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA928744.csv.gz"}},{"accession":"PRJNA1455662","age_categories":{"adult":70},"countries":{"US":70},"first_public_year":"2026","gbp_per_sample_median":26.07,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":70},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":70,"papers":[{"doi":"10.21203/rs.3.rs-10107631/v1","pmcid":null,"pmid":null,"title":"Metagenomic and Metabolomic Correlates of Immunotherapy Response in Non-Small Cell Lung Cancer"}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic and Metabolomic Determinants of Immunotherapy Response in Non-Small Cell Lung Cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1455662","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1455662_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1455662.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1455662.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1455662.csv.gz"}},{"accession":"PRJNA1226730","age_categories":{"unknown":68},"countries":{"CN":68},"first_public_year":"2026","gbp_per_sample_median":6.65,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":68},"intervention_design":"single_arm_before_after","intervention_detail":"Neoadjuvant tislelizumab (anti-PD-1) plus platinum-based doublet chemotherapy","interventions":["drug_therapy"],"n_samples":68,"papers":[{"doi":"10.1002/ctm2.70579","pmcid":"PMC12778419","pmid":"41499358","title":"Baseline multi-omics signatures could predict therapeutic response to neoadjuvant anti-PD-1 immunochemotherapy in non-small-cell lung cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Gut metagenome_Homo sapiens_PD1 Raw sequence reads","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1226730","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1226730_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1226730.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1226730.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1226730.csv.gz"}},{"accession":"PRJNA905672","age_categories":{"adult":32,"elderly":34,"unknown":2},"countries":{"TN":68},"first_public_year":"2023","gbp_per_sample_median":0.24,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":35,"other_cancer":33},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":68,"papers":[{"doi":"10.3390/cimb45090477","pmcid":"PMC10527824","pmid":"37754261","title":"Colorectal Cancer Archaeome: A Metagenomic Exploration, Tunisia."}],"sample_intervention_arms":{},"sex":{"female":39,"male":29},"title":"Metagenomic data of gut microbiome from tunisian CRC patients","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA905672","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA905672_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA905672.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA905672.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA905672.csv.gz"}},{"accession":"PRJEB53954","age_categories":{"unknown":67},"countries":{"CA":67},"first_public_year":"2022","gbp_per_sample_median":0.74,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":67},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":67,"papers":[{"doi":"10.3389/fcimb.2022.924707","pmcid":"PMC9363618","pmid":"35967843","title":"Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic"},{"doi":"10.3389/fcimb.2023.1102501","pmcid":"PMC9998685","pmid":"36909730","title":"The gastrointestinal antibiotic resistome in pediatric leukemia and lymphoma patients."}],"sample_intervention_arms":{},"sex":{},"title":"Pediatric Leukemia and Lymphoma patient stool microbiome","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB53954","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB53954_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB53954.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB53954.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB53954.csv.gz"}},{"accession":"PRJEB61942","age_categories":{"adult":65},"countries":{"IT":65},"first_public_year":"2024","gbp_per_sample_median":8.2,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":65},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":65,"papers":[{"doi":"10.1016/j.chom.2024.10.006","pmcid":"PMC11629153","pmid":"39481388","title":"Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients."}],"sample_intervention_arms":{"drug_therapy":65},"sex":{},"title":"Longitudinal study of the gut microbiota during anti-pd1 immunotherapy in melanoma patients.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB61942","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB61942_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB61942.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB61942.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB61942.csv.gz"}},{"accession":"PRJNA1050903","age_categories":{"unknown":65},"countries":{},"first_public_year":"2024","gbp_per_sample_median":9.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":65},"intervention_design":"single_arm_before_after","intervention_detail":"","interventions":[],"n_samples":65,"papers":[{"doi":"10.20517/mrr.2024.49","pmcid":"PMC11977384","pmid":"40207279","title":"Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin."},{"doi":"10.21203/rs.3.rs-3787741/v1","pmcid":null,"pmid":null,"title":"Profiling the gut and oral microbiota of hormone-receptor positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin"}],"sample_intervention_arms":{"drug_therapy":37,"no_intervention":28},"sex":{"female":65},"title":"Human gut metagenome Raw sequence reads","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1050903","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1050903_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1050903.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1050903.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1050903.csv.gz"}},{"accession":"PRJNA1065874","age_categories":{"adult":36,"elderly":29},"countries":{"TW":65},"first_public_year":"2024","gbp_per_sample_median":7.12,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":32,"other_disease":33},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":65,"papers":[{"doi":"10.1186/s12866-024-03219-2","pmcid":"PMC11040827","pmid":"38658841","title":"Microbiome signatures associated with clinical stages of gastric Cancer: whole metagenome shotgun sequencing study."}],"sample_intervention_arms":{},"sex":{"female":42,"male":23},"title":"Gut microbiome associated with gastric cancer and chronic gastritis","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1065874","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1065874_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1065874.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1065874.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1065874.csv.gz"}},{"accession":"PRJNA1263414","age_categories":{"adult":45,"elderly":17},"countries":{"RU":62},"first_public_year":"2025","gbp_per_sample_median":2.21,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":62},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":62,"papers":[{"doi":"10.1080/19490976.2026.2681788","pmcid":"PMC13274128","pmid":"42298353","title":"Gut microbial markers of immunotherapy response in melanoma: a cross-cohort analysis including the first Russian dataset."}],"sample_intervention_arms":{},"sex":{"female":37,"male":25},"title":"Human gut metagenome from melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1263414","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1263414_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1263414.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1263414.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1263414.csv.gz"}},{"accession":"PRJNA1473477","age_categories":{"unknown":62},"countries":{"KR":62},"first_public_year":"2026","gbp_per_sample_median":10.91,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":62},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":62,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome of long-term remission DLBCL patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1473477","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1473477_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1473477.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1473477.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1473477.csv.gz"}},{"accession":"PRJEB110927","age_categories":{"adult":35,"elderly":18,"unknown":8},"countries":{"FR":61},"first_public_year":"2026","gbp_per_sample_median":6.83,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"FOLFIRI + durvalumab with or without tremelimumab","interventions":["drug_therapy"],"n_samples":61,"papers":[{"doi":"10.1053/j.gastro.2024.10.020","pmcid":null,"pmid":"39454892","title":"Faecalibacteriumprausnitzii Is Associated With Clinical Response to Immune Checkpoint Inhibitors in Patients With Advanced Gastric Adenocarcinoma: Results of Microbiota Analysis of PRODIGE 59-FFCD 170"}],"sample_intervention_arms":{},"sex":{"female":22,"male":34},"title":"Durigast_F_prausnitzii_ICI_gastric_adenocarcinoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB110927","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB110927_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB110927.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB110927.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB110927.csv.gz"}},{"accession":"PRJNA1042648","age_categories":{"unknown":60},"countries":{"FR":60},"first_public_year":"2024","gbp_per_sample_median":3.11,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":60},"intervention_design":"observational_with_procedure","intervention_detail":"Immune checkpoint blockers and/or chemotherapy for NSCLC","interventions":["drug_therapy"],"n_samples":60,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Metabolic tumor burden assessed by [18F] FDG - PET CT scan as a predictive biomarker for immune checkpoint blockers in advanced NSCLC and its biological correlates: a multicentric study.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1042648","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1042648_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1042648.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1042648.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1042648.csv.gz"}},{"accession":"PRJNA813705","age_categories":{"adult":60},"countries":{"BE":60},"first_public_year":"2024","gbp_per_sample_median":20.25,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":30,"other_cancer":30},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":60,"papers":[{"doi":"10.3324/haematol.2023.284138","pmcid":"PMC11443375","pmid":"38546675","title":"Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia."}],"sample_intervention_arms":{},"sex":{},"title":"Evaluation of gut microbiota composition in patients with acute myeloid leukemia","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA813705","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA813705_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA813705.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA813705.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA813705.csv.gz"}},{"accession":"PRJEB84128","age_categories":{"adult":57},"countries":{"ES":57},"first_public_year":"2025","gbp_per_sample_median":2.59,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Androgen receptor pathway inhibitor (ARPI) therapy for metastatic prostate cancer","interventions":["drug_therapy"],"n_samples":57,"papers":[{"doi":"10.21203/rs.3.rs-5837549/v1","pmcid":null,"pmid":null,"title":"Gut microbiota metabolic reprogramming in metastatic prostatic cancer: prognostic value in patients under androgen receptor pathway inhibitors therapy."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota signatures associated with advanced metastatic prostatic cancer treated with androgen receptor pathway inhibitor therapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB84128","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB84128_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB84128.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB84128.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB84128.csv.gz"}},{"accession":"PRJNA1173329","age_categories":{"unknown":57},"countries":{},"first_public_year":"2025","gbp_per_sample_median":13.8,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":57},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":57,"papers":[{"doi":"10.1016/j.identj.2026.109621","pmcid":"PMC13202295","pmid":"42134193","title":"MMP1 Modulates Head and Neck Squamous Cell Carcinoma Progression and Therapeutic Response Via Tumour Microenvironment."}],"sample_intervention_arms":{},"sex":{},"title":"Mechanistic Study of Head and Neck Squamous Cell Carcinoma Based on Microbiomics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1173329","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1173329_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1173329.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1173329.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1173329.csv.gz"}},{"accession":"PRJNA1235679","age_categories":{"adolescent":24,"adult":6,"child":27},"countries":{"US":57},"first_public_year":"2025","gbp_per_sample_median":6.04,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":30,"other_cancer":27},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":57,"papers":[{"doi":null,"pmcid":null,"pmid":"42520232","title":"Shotgun Metagenomics Identify Unique Changes of the Intestinal Microbiome in Pediatric Survivors of Acute Lymphoblastic Leukemia."},{"doi":"10.22541/au.174228170.06111907/v1","pmcid":null,"pmid":null,"title":"Gut Microbiome Shotgun Metagenomic Sequencing in Survivors of Acute Lymphoblastic Leukemia Compared to Siblings"}],"sample_intervention_arms":{},"sex":{},"title":"Gut Microbiome Shotgun Metagenomic Sequencing in Survivors of Acute Lymphoblastic Leukemia Compared to Siblings","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1235679","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1235679_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1235679.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1235679.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1235679.csv.gz"}},{"accession":"PRJNA1372073","age_categories":{"unknown":57},"countries":{"CN":57},"first_public_year":"2026","gbp_per_sample_median":13.59,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":5,"liver_disease":52},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":57,"papers":[{"doi":"10.1002/imt2.70123","pmcid":"PMC13147943","pmid":"42099457","title":"Two stable gut microbiome guilds predict liver tumor class and treatment responses."}],"sample_intervention_arms":{},"sex":{},"title":"Hepatocellular Carcinoma Cohort Metagenomics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1372073","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1372073_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1372073.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1372073.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1372073.csv.gz"}},{"accession":"PRJNA665854","age_categories":{"adult":57},"countries":{"JP":57},"first_public_year":"2020","gbp_per_sample_median":0.51,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":18,"other_cancer":39},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":57,"papers":[{"doi":null,"pmcid":"PMC8263681","pmid":"34249452","title":"Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors."},{"doi":"10.1097/js9.0000000000001762","pmcid":"PMC11487005","pmid":"38874485","title":"The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing."}],"sample_intervention_arms":{},"sex":{},"title":"WGS of feces and saliva of pancreatic cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA665854","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA665854_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA665854.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA665854.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA665854.csv.gz"}},{"accession":"PRJEB101146","age_categories":{"adult":56},"countries":{"DE":56},"first_public_year":"2025","gbp_per_sample_median":3.34,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":56},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":56,"papers":[{"doi":"10.1016/j.cell.2026.09.004","pmcid":null,"pmid":"42805174","title":"Opposing functions of gut immunomodulatory metabolites on CAR-T therapy."}],"sample_intervention_arms":{},"sex":{},"title":"Opposing Functions of Gut Immunomodulatory Metabolites on CAR-T Therapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB101146","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB101146_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB101146.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB101146.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB101146.csv.gz"}},{"accession":"PRJNA1216225","age_categories":{"adult":56},"countries":{"TR":56},"first_public_year":"2025","gbp_per_sample_median":0.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":56,"papers":[{"doi":"10.1007/s10143-025-03788-4","pmcid":null,"pmid":"40944761","title":"Unveiling gut microbiome divergence in sellar-parasellar masses and brain tumors: A link beyond the skull."}],"sample_intervention_arms":{},"sex":{},"title":"Unveiling Gut Microbiota Divergence in Sellar-Parasellar Masses and Brain Tumors: A Link Beyond the Skull","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1216225","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1216225_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1216225.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1216225.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1216225.csv.gz"}},{"accession":"PRJNA833034","age_categories":{"adolescent":4,"adult":49,"child":1,"elderly":2},"countries":{"CN":56},"first_public_year":"2022","gbp_per_sample_median":6.5,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":56},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":56,"papers":[{"doi":"10.1002/advs.202400684","pmcid":"PMC11497089","pmid":"39225628","title":"Integrated Microbiome and Metabolome Analysis Reveals Hypothalamic-Comorbidities Related Signatures in Craniopharyngioma."}],"sample_intervention_arms":{},"sex":{"female":21,"male":35},"title":"Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota in patients with craniopharyngioma","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA833034","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA833034_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA833034.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA833034.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA833034.csv.gz"}},{"accession":"PRJNA1154401","age_categories":{"adult":54},"countries":{"CN":54},"first_public_year":"2024","gbp_per_sample_median":6.81,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":54},"intervention_design":"unknown","intervention_detail":"anti-PD-1/PD-L1 immune checkpoint inhibitor therapy in lung cancer patients","interventions":[],"n_samples":54,"papers":[{"doi":"10.1016/j.ebiom.2024.105427","pmcid":"PMC11550776","pmid":"39471749","title":"Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1154401","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1154401_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1154401.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1154401.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1154401.csv.gz"}},{"accession":"PRJEB78503","age_categories":{"unknown":52},"countries":{"FR":52},"first_public_year":"2025","gbp_per_sample_median":24.54,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":52},"intervention_design":"single_arm_before_after","intervention_detail":"High-dose methotrexate-based polychemotherapy, samples before/after therapy","interventions":["drug_therapy"],"n_samples":52,"papers":[{"doi":"10.1093/neuonc/noaf059","pmcid":"PMC12448904","pmid":"40048707","title":"Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome study on Primary central nervous system lymphoma (PCNSL) demonstrates that chemotherapy response modulation is driven by specific microorganisms through the gut-brain axis.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB78503","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB78503_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB78503.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB78503.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB78503.csv.gz"}},{"accession":"PRJNA999651","age_categories":{"unknown":52},"countries":{"US":52},"first_public_year":"2023","gbp_per_sample_median":11.94,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":14,"transplant_or_immunocompromised":38},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":52,"papers":[{"doi":"10.1038/s41467-023-42998-6","pmcid":"PMC10645880","pmid":"37963868","title":"Clinically relevant antibiotic resistance genes are linked to a limited set of taxa within gut microbiome worldwide."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomes from stool of hospitalized neutropenic patients","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA999651","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA999651_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA999651.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA999651.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA999651.csv.gz"}},{"accession":"PRJNA1030952","age_categories":{"adult":47,"elderly":4},"countries":{"JP":51},"first_public_year":"2023","gbp_per_sample_median":7.77,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":1,"crohns_disease":9,"healthy_control":10,"ibs":14,"other_cancer":6,"ulcerative_colitis":11},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":51,"papers":[{"doi":"10.1186/s40168-024-01903-z","pmcid":"PMC11446047","pmid":"39358771","title":"A single amplified genome catalog reveals the dynamics of mobilome and resistome in the human microbiome."},{"doi":"10.1101/2025.06.16.659887","pmcid":null,"pmid":null,"title":"Biome-specific genome catalogues reveal functional potential of shallow sequencing"}],"sample_intervention_arms":{},"sex":{"female":28,"male":23},"title":"Single-cell and metagenome sequencing for human oral/gut microbiome","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1030952","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1030952_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1030952.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1030952.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1030952.csv.gz"}},{"accession":"PRJNA1130699","age_categories":{"adult":19,"elderly":32},"countries":{"KR":51},"first_public_year":"2024","gbp_per_sample_median":17.72,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":51},"intervention_design":"observational_with_procedure","intervention_detail":"Anti-PD-L1/anti-PD-1 immune checkpoint blockade therapy","interventions":["drug_therapy"],"n_samples":51,"papers":[{"doi":"10.1038/s41467-024-55388-3","pmcid":"PMC11680825","pmid":"39730328","title":"A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapy."}],"sample_intervention_arms":{"drug_therapy":51},"sex":{"female":12,"male":39},"title":"Whole metagenomic shotgun sequencing on fecal samples of NSCLC patients who received ICB treatment","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1130699","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1130699_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1130699.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1130699.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1130699.csv.gz"}},{"accession":"PRJNA505228","age_categories":{"adult":50},"countries":{"CN":50},"first_public_year":"2019","gbp_per_sample_median":10.54,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":50},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":50,"papers":[{"doi":"10.1186/s40425-019-0650-9","pmcid":"PMC6651993","pmid":"31337439","title":"Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma."},{"doi":"10.1126/sciadv.adp8266","pmcid":"PMC11446285","pmid":"39356756","title":"Activation of NOD1 on tumor-associated macrophages augments CD8<sup>+</sup> T cell-mediated antitumor immunity in hepatocellular carcinoma."},{"doi":"10.1136/jitc-2025-013755","pmcid":"PMC12918670","pmid":"41702649","title":"Modulating <i>Bacteroides</i> to boost anti-PD-1 immunotherapy in HCC."},{"doi":"10.1158/1078-0432.ccr-20-4834","pmcid":"PMC9053858","pmid":"33593881","title":"A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiome of patients under immunotherapy in China","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA505228","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA505228_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA505228.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA505228.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA505228.csv.gz"}},{"accession":"PRJNA1083602","age_categories":{"unknown":49},"countries":{"ES":49},"first_public_year":"2025","gbp_per_sample_median":3.11,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":18,"other_cancer":11,"other_disease":20},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":49,"papers":[{"doi":"10.3390/ijms252010988","pmcid":"PMC11507633","pmid":"39456772","title":"Metagenomic Study Reveals Phage-Bacterial Interactome Dynamics in Gut and Oral Microbiota in Pancreatic Diseases."}],"sample_intervention_arms":{},"sex":{},"title":"Microbial diversity in the human gut affected by pancreatic diseases","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1083602","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1083602_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1083602.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1083602.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1083602.csv.gz"}},{"accession":"PRJNA746114","age_categories":{"adult":49},"countries":{"CN":49},"first_public_year":"2021","gbp_per_sample_median":12.57,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":49},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":49,"papers":[{"doi":"10.3389/fcimb.2022.892401","pmcid":"PMC9200620","pmid":"35719339","title":"Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy."},{"doi":"10.1016/j.isci.2025.113163","pmcid":"PMC12335974","pmid":"40792028","title":"Stability of gut microbiota in non-small cell lung cancer patients during chemoradiotherapy and its association with radiation pneumonitis."}],"sample_intervention_arms":{},"sex":{},"title":"lung cancer biomarker Raw sequence reads","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA746114","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA746114_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA746114.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA746114.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA746114.csv.gz"}},{"accession":"PRJEB85676","age_categories":{"adult":48},"countries":{"FR":48},"first_public_year":"2025","gbp_per_sample_median":3.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":48},"intervention_design":"single_arm_before_after","intervention_detail":"Low-dose intestinal irradiation + PD-L1 blockade, phase 2 trial","interventions":["drug_therapy","other_intervention"],"n_samples":48,"papers":[{"doi":"10.1016/j.ccell.2025.02.010","pmcid":"PMC11907695","pmid":"40068595","title":"Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients."}],"sample_intervention_arms":{},"sex":{},"title":"Low-Dose Irradiation of the Gut Improves the Efficacy of PD-L1 Blockade in Metastatic Cancer Patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB85676","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB85676_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB85676.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB85676.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB85676.csv.gz"}},{"accession":"PRJNA541981","age_categories":{"adult":15,"elderly":33},"countries":{"US":48},"first_public_year":"2019","gbp_per_sample_median":4.59,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":48},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":48,"papers":[{"doi":"10.1186/s13073-019-0672-4","pmcid":"PMC6785875","pmid":"31597568","title":"Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients."},{"doi":"10.1186/s13073-021-00974-z","pmcid":"PMC8513370","pmid":"34641962","title":"Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma."},{"doi":"10.1084/jem.20200606","pmcid":"PMC7664509","pmid":"33175106","title":"Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers."},{"doi":"10.1172/jci.insight.140940","pmcid":"PMC7714408","pmid":"33268597","title":"Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma."},{"doi":"10.1158/1078-0432.ccr-20-4834","pmcid":"PMC9053858","pmid":"33593881","title":"A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors."}],"sample_intervention_arms":{"drug_therapy":48},"sex":{"female":6,"male":42},"title":"Gut microbiome in melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA541981","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA541981_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA541981.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA541981.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA541981.csv.gz"}},{"accession":"PRJEB46214","age_categories":{"unknown":47},"countries":{"CA":47},"first_public_year":"2021","gbp_per_sample_median":1.0,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":47},"intervention_design":"single_arm_before_after","intervention_detail":"Pegaspargase chemotherapy treatment in pediatric ALL patients, sampled over treatment","interventions":["drug_therapy"],"n_samples":47,"papers":[{"doi":"10.1080/10428194.2021.1953006","pmcid":null,"pmid":"34279176","title":"Gut bacterial gene changes following pegaspargase treatment in pediatric patients with acute lymphoblastic leukemia."},{"doi":"10.3389/fcimb.2022.924707","pmcid":"PMC9363618","pmid":"35967843","title":"Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic"},{"doi":"10.3389/fcimb.2023.1102501","pmcid":"PMC9998685","pmid":"36909730","title":"The gastrointestinal antibiotic resistome in pediatric leukemia and lymphoma patients."}],"sample_intervention_arms":{},"sex":{},"title":"Gut bacterial gene changes following pegaspargase treatment in pediatric patients with Acute Lymphoblastic Leukemia","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB46214","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46214_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB46214.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB46214.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46214.csv.gz"}},{"accession":"PRJNA1391873","age_categories":{"adult":47},"countries":{"CN":47},"first_public_year":"2025","gbp_per_sample_median":7.92,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":47},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":47,"papers":[{"doi":"10.3389/fonc.2025.1683347","pmcid":"PMC12992022","pmid":"41853758","title":"Correlation between gut microbiota and their metabolites and the efficacy of chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Correlation between gut microbiota and their metabolites and the efficacy of chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1391873","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1391873_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1391873.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1391873.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1391873.csv.gz"}},{"accession":"PRJNA1219628","age_categories":{"adult":46},"countries":{"CA":46},"first_public_year":"2025","gbp_per_sample_median":0.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":46},"intervention_design":"single_arm_before_after","intervention_detail":"MET4 bacterial consortium given to immune checkpoint inhibitor recipients","interventions":["live_biotherapeutic"],"n_samples":46,"papers":[{"doi":"10.1136/jitc-2024-010681","pmcid":"PMC11979602","pmid":"40121033","title":"Microbial Ecosystem Therapeutics 4 (MET4) elicits treatment-specific IgG responses associated with changes in gut microbiota in immune checkpoint inhibitor recipients with advanced solid tumors."},{"doi":"10.1128/mbio.01904-25","pmcid":"PMC12607873","pmid":"40996271","title":"Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trial."}],"sample_intervention_arms":{"live_biotherapeutic":23,"no_intervention":23},"sex":{},"title":"MET4 recipient stools","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1219628","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1219628_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1219628.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1219628.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1219628.csv.gz"}},{"accession":"PRJNA1142390","age_categories":{"adult":45},"countries":{"CN":45},"first_public_year":"2024","gbp_per_sample_median":6.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":45},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":45,"papers":[{"doi":"10.3389/fgene.2024.1366131","pmcid":"PMC11484251","pmid":"39421302","title":"Gut microbiota as a prognostic biomarker for unresectable hepatocellular carcinoma treated with anti-PD-1 therapy."},{"doi":"10.1002/imt2.70123","pmcid":"PMC13147943","pmid":"42099457","title":"Two stable gut microbiome guilds predict liver tumor class and treatment responses."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1142390","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1142390_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1142390.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1142390.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1142390.csv.gz"}},{"accession":"PRJNA643802","age_categories":{"adult":45},"countries":{"IT":45},"first_public_year":"2020","gbp_per_sample_median":2.89,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":2,"other_cancer":26,"other_disease":17},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo FMT for TKI-induced diarrhoea in RCC patients","interventions":["fmt"],"n_samples":45,"papers":[{"doi":"10.1038/s41467-020-18127-y","pmcid":"PMC7455693","pmid":"32859933","title":"Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":32},"sex":{},"title":"FMT for diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA643802","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA643802_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA643802.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA643802.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA643802.csv.gz"}},{"accession":"PRJEB29237","age_categories":{"child":44},"countries":{"CA":44},"first_public_year":"2018","gbp_per_sample_median":0.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":44},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":44,"papers":[{"doi":"10.3389/fcimb.2019.00028","pmcid":"PMC6389711","pmid":"30838178","title":"Infectious Complications Are Associated With Alterations in the Gut Microbiome in Pediatric Patients With Acute Lymphoblastic Leukemia."},{"doi":"10.3389/fcimb.2022.924707","pmcid":"PMC9363618","pmid":"35967843","title":"Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic"},{"doi":"10.3389/fcimb.2023.1102501","pmcid":"PMC9998685","pmid":"36909730","title":"The gastrointestinal antibiotic resistome in pediatric leukemia and lymphoma patients."}],"sample_intervention_arms":{},"sex":{},"title":"16S rRNA gene amplicon and metagenomic shotgun sequencing reads from a pediatric acute lymphoblastic leukemia cohort. Metagenomic shotgun sequencing reads have been prefiltered to remove any human DNA before uploading to following ethical guidelines for the study.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB29237","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB29237_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB29237.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB29237.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB29237.csv.gz"}},{"accession":"PRJNA1153928","age_categories":{"unknown":44},"countries":{"US":44},"first_public_year":"2024","gbp_per_sample_median":2.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":44},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":44,"papers":[{"doi":"10.1136/jitc-2024-011356","pmcid":"PMC12258320","pmid":"40639850","title":"Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study."}],"sample_intervention_arms":{"antibiotic":19,"no_intervention":25},"sex":{},"title":"Immune System Modulation with Oral Vancomycin in combination with Stereotactic Body Radiotherapy (SBRT) for medically inoperable Early-Stage Non-small Cell Lung Cancer","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1153928","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1153928_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1153928.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1153928.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1153928.csv.gz"}},{"accession":"PRJNA302832","age_categories":{"unknown":44},"countries":{"US":44},"first_public_year":"2015","gbp_per_sample_median":0.56,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":44},"intervention_design":"observational_with_procedure","intervention_detail":"Ipilimumab (CTLA-4 blockade) immunotherapy in melanoma patients","interventions":["drug_therapy"],"n_samples":44,"papers":[{"doi":"10.1371/journal.pone.0198773","pmcid":"PMC6002052","pmid":"29902201","title":"When old metagenomic data meet newly sequenced genomes, a case study."},{"doi":"10.1186/s13073-024-01285-9","pmcid":"PMC10799412","pmid":"38243343","title":"Gut microbiome for predicting immune checkpoint blockade-associated adverse events."},{"doi":"10.1038/ncomms10391","pmcid":"PMC4740747","pmid":"26837003","title":"Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis."}],"sample_intervention_arms":{},"sex":{},"title":"Human gut Metagenome","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA302832","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA302832_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA302832.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA302832.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA302832.csv.gz"}},{"accession":"PRJNA397906","age_categories":{"adult":17,"elderly":22,"unknown":5},"countries":{"US":44},"first_public_year":"2017","gbp_per_sample_median":9.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":44},"intervention_design":"observational_with_procedure","intervention_detail":"Immune checkpoint inhibitor therapy in melanoma patients","interventions":["drug_therapy"],"n_samples":44,"papers":[{"doi":"10.1016/j.neo.2017.08.004","pmcid":"PMC5602478","pmid":"28923537","title":"Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients."},{"doi":"10.1093/g3journal/jkab046","pmcid":"PMC8049424","pmid":"33713107","title":"MetaPrism: A versatile toolkit for joint taxa/gene analysis of metagenomic sequencing data."},{"doi":"10.1016/j.xpro.2024.102847","pmcid":"PMC10837094","pmid":"38277270","title":"Protocol to identify fungal profile from fecal metagenomes in cancer patients prior to immunotherapy."},{"doi":"10.1016/j.slast.2025.100365","pmcid":null,"pmid":"41241214","title":"Technology-enabled integration of single-cell transcriptomics and microbiome data identifies RNA-targetable host-microbiota networks in colorectal adenoma."},{"doi":"10.1084/jem.20200606","pmcid":"PMC7664509","pmid":"33175106","title":"Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers."}],"sample_intervention_arms":{},"sex":{"female":9,"male":30},"title":"Metagenomic shotgun sequencing of gut microbiomes of melanoma patients receiving immune checkpoint inhibitor therapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA397906","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA397906_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA397906.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA397906.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA397906.csv.gz"}},{"accession":"PRJNA800058","age_categories":{"adult":43},"countries":{"CA":43},"first_public_year":"2022","gbp_per_sample_median":10.27,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":43},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":43,"papers":[{"doi":"10.1080/2162402x.2022.2096535","pmcid":"PMC9272833","pmid":"35832043","title":"Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors."}],"sample_intervention_arms":{},"sex":{},"title":"Helicobacter pylori serology is negatively associated with overall survival in patients with melanoma treated with immune checkpoint inhibitors","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA800058","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA800058_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA800058.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA800058.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA800058.csv.gz"}},{"accession":"PRJNA971748","age_categories":{"unknown":43},"countries":{"CA":43},"first_public_year":"2023","gbp_per_sample_median":6.69,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":43},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":43,"papers":[{"doi":"10.1016/j.oraloncology.2023.106623","pmcid":null,"pmid":"38006691","title":"Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome predicts toxicity outcomes from chemoradiation therapy in HNSCC","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA971748","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA971748_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA971748.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA971748.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA971748.csv.gz"}},{"accession":"PRJNA678737","age_categories":{"unknown":42},"countries":{"IL":42},"first_public_year":"2021","gbp_per_sample_median":4.73,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":23},"intervention_design":"single_arm_before_after","intervention_detail":"FMT with anti-PD-1 re-induction in refractory metastatic melanoma, phase I trial","interventions":["fmt"],"n_samples":42,"papers":[{"doi":"10.1186/s12866-021-02312-0","pmcid":"PMC8454007","pmid":"34544375","title":"Incongruence between dominant commensal donor microbes in recipient feces post fecal transplant and response to anti-PD-1 immunotherapy."},{"doi":"10.1126/science.aaz7015","pmcid":"PMC8970537","pmid":"34941392","title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response."},{"doi":"10.1128/msystems.01023-22","pmcid":"PMC10134792","pmid":"36809182","title":"Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy."},{"doi":"10.1038/s41522-023-00421-4","pmcid":"PMC10400536","pmid":"37537181","title":"Donor-recipient specificity and age-dependency in fecal microbiota therapy and probiotic resolution of gastrointestinal symptoms."},{"doi":"10.1186/s13073-024-01285-9","pmcid":"PMC10799412","pmid":"38243343","title":"Gut microbiome for predicting immune checkpoint blockade-associated adverse events."}],"sample_intervention_arms":{"drug_therapy":23},"sex":{},"title":"Fecal microbiota transplantation modulates immunotherapy response in refractory metastatic melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA678737","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA678737_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA678737.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA678737.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA678737.csv.gz"}},{"accession":"PRJNA1043252","age_categories":{"adult":41},"countries":{"KR":41},"first_public_year":"2023","gbp_per_sample_median":2.33,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"neurological_psychiatric":41},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":41,"papers":[{"doi":"10.1136/gutjnl-2024-333530","pmcid":"PMC12013593","pmid":"39653411","title":"Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway."},{"doi":"10.4143/crt.2024.675","pmcid":"PMC12016819","pmid":"39164084","title":"Clinical Impact of Microbiome Characteristics in Treatment-Naïve Extranodal NK/T-Cell Lymphoma Patients."}],"sample_intervention_arms":{},"sex":{},"title":"ENKTL shotgun metagenome","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1043252","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1043252_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1043252.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1043252.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1043252.csv.gz"}},{"accession":"PRJNA702617","age_categories":{"adult":41},"countries":{"US":41},"first_public_year":"2021","gbp_per_sample_median":5.96,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":41},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":41,"papers":[{"doi":"10.1186/s12885-022-09997-0","pmcid":"PMC9438314","pmid":"36050658","title":"Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure."},{"doi":"10.1016/j.ccell.2023.09.012","pmcid":"PMC10841640","pmid":"37863066","title":"Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring."}],"sample_intervention_arms":{},"sex":{},"title":"Shotgun Metagenome Sequencing of Rectal Swab Samples from Cervical Cancer Patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA702617","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA702617_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA702617.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA702617.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA702617.csv.gz"}},{"accession":"PRJNA1261620","age_categories":{"unknown":40},"countries":{"JP":40},"first_public_year":"2025","gbp_per_sample_median":0.55,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":40},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":40,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"HCC_gut_microbiome","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1261620","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1261620_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1261620.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1261620.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1261620.csv.gz"}},{"accession":"PRJNA314481","age_categories":{"adult":31,"elderly":9},"countries":{},"first_public_year":"2016","gbp_per_sample_median":0.71,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_adenoma":10,"healthy_control":20,"other_cancer":10},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":40,"papers":[],"sample_intervention_arms":{},"sex":{"female":23,"male":17},"title":"Bacteria and human colon samples from human gut Metagenome","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA314481","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA314481_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA314481.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA314481.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA314481.csv.gz"}},{"accession":"PRJNA615114","age_categories":{"unknown":40},"countries":{"CN":40},"first_public_year":"2020","gbp_per_sample_median":7.61,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":40},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":40,"papers":[{"doi":"10.1016/j.isci.2025.112162","pmcid":"PMC11937697","pmid":"40151642","title":"Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types."},{"doi":"10.3390/microorganisms13112595","pmcid":"PMC12654497","pmid":"41304278","title":"Multi-Kingdom Gut Microbiome Interaction Characteristics Predict Immune Checkpoint Inhibitor Efficacy Across Pan-Cancer Cohorts."},{"doi":"10.34133/csbj.0065","pmcid":"PMC13173278","pmid":"42146906","title":"Ecological and Functional Stratification of the Stool Microbiome Predicts Response to Immune Checkpoint Inhibitors across Cancer Types."}],"sample_intervention_arms":{},"sex":{},"title":"The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA615114","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA615114_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA615114.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA615114.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA615114.csv.gz"}},{"accession":"PRJNA944152","age_categories":{"adult":15,"elderly":25},"countries":{"CA":25,"FR":15},"first_public_year":"2023","gbp_per_sample_median":2.71,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":40,"papers":[],"sample_intervention_arms":{},"sex":{"female":21,"male":19},"title":"sMadCam-1 associations with the gut microbiome in NSCLC cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA944152","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA944152_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA944152.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA944152.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA944152.csv.gz"}},{"accession":"PRJEB108219","age_categories":{"unknown":39},"countries":{"AE":39},"first_public_year":"2026","gbp_per_sample_median":0.75,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":39},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":39,"papers":[],"sample_intervention_arms":{},"sex":{"female":39},"title":"This project investigates the role of the human microbiota in breast cancer through multi-site and longitudinal microbiome profiling.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB108219","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB108219_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB108219.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB108219.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB108219.csv.gz"}},{"accession":"PRJNA399742","age_categories":{"adult":39},"countries":{"US":39},"first_public_year":"2018","gbp_per_sample_median":10.79,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":39},"intervention_design":"observational_with_procedure","intervention_detail":"Human baseline stool samples; FMT into germ-free mice from responding vs non-responding patient","interventions":[],"n_samples":39,"papers":[{"doi":"10.1126/science.aao3290","pmcid":"PMC6707353","pmid":"29302014","title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients."},{"doi":"10.1111/bjd.20626","pmcid":"PMC9293081","pmid":"34227096","title":"Early melanoma invasivity correlates with gut fungal and bacterial profiles."},{"doi":"10.1084/jem.20200606","pmcid":"PMC7664509","pmid":"33175106","title":"Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers."},{"doi":"10.1172/jci.insight.140940","pmcid":"PMC7714408","pmid":"33268597","title":"Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma."},{"doi":"10.1158/1078-0432.ccr-20-4834","pmcid":"PMC9053858","pmid":"33593881","title":"A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors."}],"sample_intervention_arms":{},"sex":{},"title":"Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA399742","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA399742_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA399742.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA399742.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA399742.csv.gz"}},{"accession":"PRJEB58222","age_categories":{"adult":37},"countries":{"DE":37},"first_public_year":"2023","gbp_per_sample_median":9.63,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":37},"intervention_design":"unknown","intervention_detail":"FMT, tryptophan diet manipulation, oral 3-IAA, chemotherapy in mouse models; human cohorts observed","interventions":["diet_intervention","dietary_supplement","drug_therapy","fmt"],"n_samples":37,"papers":[{"doi":"10.1038/s41586-023-05728-y","pmcid":"PMC9977685","pmid":"36813961","title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB58222","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58222_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB58222.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB58222.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58222.csv.gz"}},{"accession":"PRJNA1371343","age_categories":{"adult":37},"countries":{"CH":2,"GB":23,"IT":12},"first_public_year":"2026","gbp_per_sample_median":3.75,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":37},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":37,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Gut metagenome analysis of prostate cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1371343","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1371343_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1371343.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1371343.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1371343.csv.gz"}},{"accession":"PRJEB68381","age_categories":{"adult":18,"elderly":17},"countries":{"DE":35},"first_public_year":"2023","gbp_per_sample_median":0.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":9,"neurological_psychiatric":1,"other_cancer":1,"other_disease":17,"type2_diabetes":7},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":35,"papers":[{"doi":"10.1136/gutjnl-2023-330987","pmcid":"PMC10894816","pmid":"38129103","title":"Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis."}],"sample_intervention_arms":{},"sex":{"male":31},"title":"Pancreatitis - Microbiome As Predictor of Severity P-MAPS","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB68381","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB68381_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB68381.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB68381.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB68381.csv.gz"}},{"accession":"PRJNA1469454","age_categories":{"adult":24,"elderly":8},"countries":{"RU":32},"first_public_year":"2026","gbp_per_sample_median":4.44,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":32},"intervention_design":"unknown","intervention_detail":"Immune checkpoint inhibitor immunotherapy, pre- vs 3-month post-treatment","interventions":["drug_therapy"],"n_samples":32,"papers":[],"sample_intervention_arms":{},"sex":{"female":18,"male":14},"title":"Human gut metagenome from melanoma patients collected at two timepoints","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1469454","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1469454_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1469454.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1469454.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1469454.csv.gz"}},{"accession":"PRJNA525982","age_categories":{"adolescent":7,"child":25},"countries":{"IT":32},"first_public_year":"2019","gbp_per_sample_median":0.25,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":32},"intervention_design":"observational_with_procedure","intervention_detail":"Allogeneic hematopoietic stem cell transplantation, pre/post sampling","interventions":["surgery"],"n_samples":32,"papers":[{"doi":"10.1038/s41598-019-42222-w","pmcid":"PMC6449395","pmid":"30948795","title":"Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation."}],"sample_intervention_arms":{},"sex":{"female":7,"male":25},"title":"Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA525982","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA525982_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA525982.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA525982.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA525982.csv.gz"}},{"accession":"PRJNA626477","age_categories":{"adult":18,"elderly":12,"unknown":1},"countries":{"HU":31},"first_public_year":"2021","gbp_per_sample_median":6.12,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":31},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":31,"papers":[{"doi":"10.1038/s41396-021-00998-8","pmcid":"PMC8528809","pmid":"34002024","title":"Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients."},{"doi":"10.1371/journal.pone.0259898","pmcid":"PMC8601557","pmid":"34793492","title":"Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients."}],"sample_intervention_arms":{},"sex":{"female":12,"male":19},"title":"human gut microbiota Raw sequence reads with and without cancer cachexia","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA626477","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA626477_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA626477.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA626477.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA626477.csv.gz"}},{"accession":"PRJNA1093500","age_categories":{"adult":30},"countries":{"CN":30},"first_public_year":"2025","gbp_per_sample_median":7.36,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":15,"other_cancer":15},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":30,"papers":[{"doi":"10.1186/s12885-024-12283-w","pmcid":"PMC11044453","pmid":"38658858","title":"Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota sequencing in patients with craniopharyngioma and healthy controls","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1093500","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1093500_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1093500.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1093500.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1093500.csv.gz"}},{"accession":"PRJNA1226574","age_categories":{"adolescent":3,"child":12,"infant":15},"countries":{"IT":30},"first_public_year":"2025","gbp_per_sample_median":13.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":30},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":30,"papers":[{"doi":"10.1038/s41598-025-27280-7","pmcid":"PMC12675574","pmid":"41339392","title":"Distinct functional and compositional properties in the gut microbiome of children with acute lymphoblastic leukaemia identified by shotgun metagenomics."}],"sample_intervention_arms":{},"sex":{"female":13,"male":17},"title":"Distinct Functional and Compositional properties in the Gut Microbiome of Children with Acute Lymphoblastic Leukemia: A Shotgun Metagenomics Study","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1226574","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1226574_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1226574.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1226574.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1226574.csv.gz"}},{"accession":"PRJNA914091","age_categories":{"adult":21,"elderly":9},"countries":{"ES":30},"first_public_year":"2023","gbp_per_sample_median":4.88,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":30},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":30,"papers":[{"doi":"10.3390/microorganisms11020402","pmcid":"PMC9964539","pmid":"36838367","title":"Evaluation of a Shotgun Metagenomics Approach for Detection of ESBL- and/or Carbapenemase-Producing Enterobacterales in Culture Negative Patients Recovered from Acute Leukemia."},{"doi":"10.1038/s41598-024-56054-w","pmcid":"PMC10920697","pmid":"38454103","title":"Study of the intestinal microbiota composition and the effect of treatment with intensive chemotherapy in patients recovered from acute leukemia."}],"sample_intervention_arms":{},"sex":{"female":20,"male":10},"title":"Evaluation of a shotgun metagenomics approach for detection of ESBL- and/or carbapenemase-producing Enterobacterales in culture negative patients recovered from acute leukemia","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA914091","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA914091_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA914091.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA914091.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA914091.csv.gz"}},{"accession":"PRJNA1011235","age_categories":{"adult":29},"countries":{"DE":29},"first_public_year":"2023","gbp_per_sample_median":8.24,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":29},"intervention_design":"observational_with_procedure","intervention_detail":"Checkpoint inhibitor (anti-PD-1/anti-CTLA-4) therapy in melanoma patients","interventions":["drug_therapy"],"n_samples":29,"papers":[{"doi":"10.1186/s12885-023-11551-5","pmcid":"PMC10685659","pmid":"38017389","title":"TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients."},{"doi":"10.34133/csbj.0065","pmcid":"PMC13173278","pmid":"42146906","title":"Ecological and Functional Stratification of the Stool Microbiome Predicts Response to Immune Checkpoint Inhibitors across Cancer Types."},{"doi":"10.1080/19490976.2026.2681788","pmcid":"PMC13274128","pmid":"42298353","title":"Gut microbial markers of immunotherapy response in melanoma: a cross-cohort analysis including the first Russian dataset."}],"sample_intervention_arms":{},"sex":{},"title":"ANIMA","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1011235","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1011235_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1011235.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1011235.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1011235.csv.gz"}},{"accession":"PRJNA996050","age_categories":{"adult":11,"elderly":16},"countries":{"NL":27},"first_public_year":"2023","gbp_per_sample_median":3.69,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"colorectal_cancer":13,"other_cancer":14},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":27,"papers":[{"doi":"10.3389/fimmu.2023.1230306","pmcid":"PMC10667699","pmid":"38022530","title":"B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients."}],"sample_intervention_arms":{},"sex":{"female":14,"male":13},"title":"Fecal metagenomic profiling of vermiform appendix from adult patients with pancreatic or colon cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA996050","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA996050_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA996050.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA996050.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA996050.csv.gz"}},{"accession":"PRJDB16532","age_categories":{"adult":13,"elderly":12},"countries":{"JP":25},"first_public_year":"2024","gbp_per_sample_median":20.18,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":8,"other_cancer":17},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":25,"papers":[{"doi":"10.1016/j.heliyon.2024.e38507","pmcid":"PMC11619966","pmid":"39640675","title":"Succinic semialdehyde derived from the gut microbiota can promote the proliferation of adult T-cell leukemia/lymphoma cells."}],"sample_intervention_arms":{},"sex":{"female":12,"male":13},"title":"Generic sample from human gut metagenome","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB16532","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB16532_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB16532.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB16532.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB16532.csv.gz"}},{"accession":"PRJEB22893","age_categories":{"adult":25},"countries":{"US":25},"first_public_year":"2017","gbp_per_sample_median":3.29,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":25},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":25,"papers":[{"doi":"10.1126/science.aan4236","pmcid":"PMC5827966","pmid":"29097493","title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients."},{"doi":"10.1084/jem.20200606","pmcid":"PMC7664509","pmid":"33175106","title":"Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers."},{"doi":"10.1172/jci.insight.140940","pmcid":"PMC7714408","pmid":"33268597","title":"Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma."},{"doi":"10.1158/1078-0432.ccr-20-4834","pmcid":"PMC9053858","pmid":"33593881","title":"A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors."},{"doi":"10.1186/s13059-021-02355-6","pmcid":"PMC8097837","pmid":"33952321","title":"geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome impacts response to PD-1 immunotherapy in melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB22893","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB22893_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB22893.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB22893.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB22893.csv.gz"}},{"accession":"PRJNA1461404","age_categories":{"adult":25},"countries":{"CN":25},"first_public_year":"2026","gbp_per_sample_median":7.0,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":13,"other_cancer":12},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":25,"papers":[{"doi":"10.3389/fnut.2026.1827331","pmcid":"PMC13233540","pmid":"42253727","title":"Insights into the effects of gut microbiota and circulating metabolites on oral cancer: Mendelian randomization analysis and clinical validation."}],"sample_intervention_arms":{},"sex":{},"title":"Insights into the effects of gut microbiota and circulating metabolites on oral cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1461404","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1461404_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1461404.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1461404.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1461404.csv.gz"}},{"accession":"PRJNA896226","age_categories":{"adult":24},"countries":{"US":24},"first_public_year":"2023","gbp_per_sample_median":1.35,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":8,"other_cancer":16},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":24,"papers":[{"doi":"10.1002/cncr.34748","pmcid":null,"pmid":"36943918","title":"Analysis of the fecal metagenome in long-term survivors of pancreas cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Analysis of the Fecal Metagenome in Long Term Survivors of Pancreas Cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA896226","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA896226_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA896226.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA896226.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA896226.csv.gz"}},{"accession":"PRJNA1222800","age_categories":{"adult":13,"elderly":10},"countries":{"US":23},"first_public_year":"2025","gbp_per_sample_median":14.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":23},"intervention_design":"single_arm_before_after","intervention_detail":"Nivolumab plus low-dose ipilimumab, phase II trial, 2 years","interventions":["drug_therapy"],"n_samples":23,"papers":[{"doi":"10.1038/s41467-025-59695-1","pmcid":"PMC12075640","pmid":"40360544","title":"Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)."}],"sample_intervention_arms":{},"sex":{"female":23},"title":"Fecal metagenomes from patients with HER2-negative metastatic breast cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1222800","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1222800_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1222800.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1222800.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1222800.csv.gz"}},{"accession":"PRJEB59728","age_categories":{"unknown":22},"countries":{"CA":22},"first_public_year":"2023","gbp_per_sample_median":1.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":22},"intervention_design":"observational_with_procedure","intervention_detail":"Empiric IV β-lactam and/or vancomycin for febrile neutropenia, varying courses/duration","interventions":["antibiotic"],"n_samples":22,"papers":[{"doi":null,"pmcid":null,"pmid":null,"title":""}],"sample_intervention_arms":{},"sex":{},"title":"This study examined pediatric patients undergoing treatment for various cancers and examined the impact of antibiotic use and duration on antibiotic resistance genes","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB59728","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB59728_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB59728.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB59728.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB59728.csv.gz"}},{"accession":"PRJNA1032163","age_categories":{"unknown":20},"countries":{"CN":20},"first_public_year":"2024","gbp_per_sample_median":11.54,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":10,"other_cancer":10},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":20,"papers":[{"doi":"10.3389/fcimb.2025.1694479","pmcid":"PMC12705542","pmid":"41409546","title":"Gut-to-tumor translocation of multidrug-resistant <i>Klebsiella pneumoniae</i> shapes the microbiome and chemoresistance in pancreatic cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic analysis of fecal microbiota and its antibiotic resistom of postoperative pancreatic cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1032163","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1032163_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1032163.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1032163.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1032163.csv.gz"}},{"accession":"PRJNA1050658","age_categories":{"unknown":20},"countries":{"CN":20},"first_public_year":"2024","gbp_per_sample_median":6.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":20},"intervention_design":"single_arm_before_after","intervention_detail":"Chemotherapy and antibiotics in acute leukemia, pre/post sampling","interventions":["drug_therapy"],"n_samples":20,"papers":[{"doi":"10.1080/21505594.2024.2428843","pmcid":"PMC11622590","pmid":"39620486","title":"Exploring the dynamics of gut microbiota, antibiotic resistance, and chemotherapy impact in acute leukemia patients: A comprehensive metagenomic analysis."}],"sample_intervention_arms":{},"sex":{"female":8,"male":12},"title":"The gut microbiomes and resistomes of acute leukemia patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1050658","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1050658_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1050658.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1050658.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1050658.csv.gz"}},{"accession":"PRJNA875377","age_categories":{"unknown":20},"countries":{"BE":20},"first_public_year":"2023","gbp_per_sample_median":19.93,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":20},"intervention_design":"observational_with_procedure","intervention_detail":"Gut microbiota sampled at diagnosis, end of induction chemo, and discharge; AML patients","interventions":["other_intervention"],"n_samples":20,"papers":[{"doi":"10.1016/j.clnu.2023.09.021","pmcid":null,"pmid":"37806074","title":"Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss."}],"sample_intervention_arms":{},"sex":{},"title":"Evaluation of gut microbiota composition in patients with acute myeloid leukemia under induction chemotherapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA875377","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA875377_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA875377.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA875377.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA875377.csv.gz"}},{"accession":"PRJNA943491","age_categories":{"adult":2,"elderly":18},"countries":{"SE":20},"first_public_year":"2023","gbp_per_sample_median":4.82,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":10,"other_cancer":10},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":20,"papers":[{"doi":"10.1002/cam4.6483","pmcid":"PMC10557870","pmid":"37641475","title":"Assessment of bacterial and viral gut communities in healthy and tumoral colorectal tissue using RNA and DNA deep sequencing."}],"sample_intervention_arms":{},"sex":{"female":14,"male":6},"title":"Colorectal RNA","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA943491","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA943491_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA943491.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA943491.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA943491.csv.gz"}},{"accession":"PRJNA759070","age_categories":{"adolescent":1,"adult":18},"countries":{"CN":19},"first_public_year":"2022","gbp_per_sample_median":5.77,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":2,"healthy_control":7,"other_cancer":9,"other_disease":1},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":19,"papers":[{"doi":"10.1128/spectrum.00425-21","pmcid":"PMC8754134","pmid":"35019688","title":"Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma."}],"sample_intervention_arms":{},"sex":{"female":8,"male":3},"title":"metagenomic sequencing in patients with GHPA (growth hormone secreting pituitary adenoma)","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA759070","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA759070_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA759070.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA759070.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA759070.csv.gz"}},{"accession":"PRJNA1283527","age_categories":{"adult":18},"countries":{"US":18},"first_public_year":"2025","gbp_per_sample_median":2.63,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":18},"intervention_design":"single_arm_before_after","intervention_detail":"Radiation + nivolumab + IDO1 inhibitor BMS-986205 (+/- TMZ)","interventions":["drug_therapy"],"n_samples":18,"papers":[{"doi":"10.1158/1078-0432.ccr-26-1124","pmcid":"PMC13473868","pmid":"42189896","title":"Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205."}],"sample_intervention_arms":{},"sex":{},"title":"Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1283527","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1283527_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1283527.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1283527.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1283527.csv.gz"}},{"accession":"PRJNA1211300","age_categories":{"adult":17},"countries":{"CN":17},"first_public_year":"2025","gbp_per_sample_median":10.04,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":17},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":17,"papers":[{"doi":"10.1016/j.xcrm.2025.102370","pmcid":"PMC12629828","pmid":"41005300","title":"Phocaeicola vulgatus induces immunotherapy resistance in hepatocellular carcinoma via reducing indoleacetic acid production."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic sequencing data of hepatocellular carcinoma patients receiving immunotherapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1211300","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1211300_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1211300.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1211300.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1211300.csv.gz"}},{"accession":"PRJNA841251","age_categories":{"adult":17},"countries":{"CN":17},"first_public_year":"2022","gbp_per_sample_median":12.62,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":17},"intervention_design":"observational_with_procedure","intervention_detail":"","interventions":[],"n_samples":17,"papers":[{"doi":"10.1016/j.medj.2025.100877","pmcid":null,"pmid":"41092906","title":"Gut microbiota predictive of the efficacy of consolidation immunotherapy and chemoradiotherapy toxicity in lung cancer."},{"doi":"10.1016/j.ijrobp.2022.07.032","pmcid":null,"pmid":"35905860","title":"Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer."}],"sample_intervention_arms":{},"sex":{},"title":"The gut microbiome dynamic changes of lung cancer patients during Chemoradiotherapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA841251","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA841251_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA841251.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA841251.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA841251.csv.gz"}},{"accession":"PRJNA680692","age_categories":{"unknown":16},"countries":{"DE":16},"first_public_year":"2020","gbp_per_sample_median":1.42,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":6,"other_cancer":4,"other_disease":6},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":16,"papers":[{"doi":"10.3390/microorganisms9081701","pmcid":"PMC8401523","pmid":"34442780","title":"Differences in Gut Virome Related to Barrett Esophagus and Esophageal Adenocarcinoma."}],"sample_intervention_arms":{},"sex":{},"title":"The virome community related to esophageal disease","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA680692","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA680692_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA680692.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA680692.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA680692.csv.gz"}},{"accession":"PRJNA1153046","age_categories":{"unknown":15},"countries":{"US":15},"first_public_year":"2025","gbp_per_sample_median":7.77,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":15},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":15,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Microbiome profiling at immune checkpoint inhibitor-mediated enterocolitis onset WGS","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1153046","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1153046_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1153046.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1153046.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1153046.csv.gz"}},{"accession":"PRJNA668745","age_categories":{"adult":15},"countries":{"HU":15},"first_public_year":"2021","gbp_per_sample_median":8.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Lung resection surgery; pre- vs post-surgery stool sampling","interventions":["surgery"],"n_samples":15,"papers":[{"doi":"10.1371/journal.pone.0259898","pmcid":"PMC8601557","pmid":"34793492","title":"Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients."}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome is associated with exercise tolerance of resected early-stage lung cancer patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA668745","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA668745_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA668745.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA668745.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA668745.csv.gz"}},{"accession":"PRJNA866654","age_categories":{"unknown":15},"countries":{"US":15},"first_public_year":"2022","gbp_per_sample_median":7.54,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":15},"intervention_design":"observational_with_procedure","intervention_detail":"Immune checkpoint inhibitor immunotherapy in NSCLC patients, observed response","interventions":[],"n_samples":15,"papers":[{"doi":"10.3390/cancers14215401","pmcid":"PMC9656313","pmid":"36358819","title":"Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer."},{"doi":"10.3389/fcimb.2025.1591076","pmcid":"PMC12336193","pmid":"40792105","title":"Exploring fecal microbiota signatures associated with immune response and antibiotic impact in NSCLC: insights from metagenomic and machine learning approaches."},{"doi":"10.34133/csbj.0065","pmcid":"PMC13173278","pmid":"42146906","title":"Ecological and Functional Stratification of the Stool Microbiome Predicts Response to Immune Checkpoint Inhibitors across Cancer Types."},{"doi":"10.1007/s00262-026-04432-w","pmcid":"PMC13388844","pmid":"42189287","title":"Enterotype-specific microbial biomarkers of immune checkpoint inhibitor response revealed by large-scale integrated metagenomic analysis."}],"sample_intervention_arms":{},"sex":{},"title":"Exploring gut microbiome in predicting efficacy of immuno-therapy in non-small cell lung cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA866654","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA866654_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA866654.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA866654.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA866654.csv.gz"}},{"accession":"PRJNA915098","age_categories":{"adult":15},"countries":{"HR":15},"first_public_year":"2022","gbp_per_sample_median":2.27,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":15},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":15,"papers":[{"doi":"10.3390/cancers15113052","pmcid":"PMC10252899","pmid":"37297014","title":"Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy."},{"doi":"10.3389/fimmu.2025.1539653","pmcid":"PMC11959079","pmid":"40170844","title":"Revealing gut microbiota biomarkers associated with melanoma immunotherapy response and key bacteria-fungi interaction relationships: evidence from metagenomics, machine learning, and SHAP methodology"}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiome of melanoma patients with a complete response to immunotherapy","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA915098","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA915098_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA915098.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA915098.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA915098.csv.gz"}},{"accession":"PRJEB41463","age_categories":{"child":14},"countries":{"CA":14},"first_public_year":"2020","gbp_per_sample_median":0.38,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":14},"intervention_design":"observational_with_procedure","intervention_detail":"Pegaspargase (pegylated asparaginase) chemotherapy in pediatric ALL","interventions":["drug_therapy"],"n_samples":14,"papers":[{"doi":"10.3389/fcimb.2022.924707","pmcid":"PMC9363618","pmid":"35967843","title":"Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic"},{"doi":"10.3389/fcimb.2023.1102501","pmcid":"PMC9998685","pmid":"36909730","title":"The gastrointestinal antibiotic resistome in pediatric leukemia and lymphoma patients."},{"doi":"10.1128/spectrum.00665-23","pmcid":"PMC10269646","pmid":"37191543","title":"Exploring Molecular Interactions between Human Milk Hormone Insulin and Bifidobacteria."}],"sample_intervention_arms":{},"sex":{},"title":"Examining the gut microbial community and genes in children with acute lymphoblastic leukemia that experience different levels of change in serum asparaginase activity during pegaspargase treatment","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB41463","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB41463_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB41463.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB41463.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB41463.csv.gz"}},{"accession":"PRJEB102113","age_categories":{"adult":10},"countries":{"IN":10},"first_public_year":"2026","gbp_per_sample_median":5.11,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":4,"other_cancer":2,"other_disease":2,"pregnancy_postpartum":2},"intervention_design":"single_arm_before_after","intervention_detail":"Panchakarma Ayurvedic detoxification/rejuvenation therapy","interventions":["other_intervention"],"n_samples":10,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Mapping of the Gut Metagenome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB102113","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB102113_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB102113.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB102113.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB102113.csv.gz"}},{"accession":"PRJNA1106227","age_categories":{"unknown":10},"countries":{"CN":10},"first_public_year":"2024","gbp_per_sample_median":0.23,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":5,"other_cancer":5},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":10,"papers":[{"doi":"10.1038/s41467-025-57966-5","pmcid":"PMC11933704","pmid":"40128181","title":"Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma."}],"sample_intervention_arms":{},"sex":{},"title":"Phosphatidylcholine inactivates cytotoxic CD8+ T cells through UFMylation via exosomal SerpinB9 in multiple myeloma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1106227","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1106227_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1106227.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1106227.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1106227.csv.gz"}},{"accession":"PRJNA493153","age_categories":{"adult":10},"countries":{},"first_public_year":"2018","gbp_per_sample_median":2.84,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":10},"intervention_design":"unknown","intervention_detail":"Therapeutic HPV vaccine for HNSCC, sampled before injection","interventions":["vaccine"],"n_samples":10,"papers":[{"doi":"10.3389/fmicb.2018.03349","pmcid":"PMC6353838","pmid":"30733714","title":"SqueezeMeta, A Highly Portable, Fully Automatic Metagenomic Analysis Pipeline."},{"doi":"10.1186/s12859-020-03777-y","pmcid":"PMC7576720","pmid":"33081690","title":"CDKAM: a taxonomic classification tool using discriminative k-mers and approximate matching strategies."}],"sample_intervention_arms":{},"sex":{},"title":"Gut Microbiome Sequencing of Head and Neck Cancer Patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA493153","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA493153_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA493153.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA493153.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA493153.csv.gz"}},{"accession":"PRJNA787396","age_categories":{"unknown":10},"countries":{"IR":10},"first_public_year":"2021","gbp_per_sample_median":0.2,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":10},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":10,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Raw sequence reads of gut metagenomes of cancer patients from Iran","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA787396","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA787396_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA787396.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA787396.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA787396.csv.gz"}},{"accession":"PRJNA1176874","age_categories":{"unknown":7},"countries":{"US":7},"first_public_year":"2025","gbp_per_sample_median":8.89,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":7},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":7,"papers":[{"doi":"10.1128/mbio.01679-24","pmcid":"PMC11708054","pmid":"39584836","title":"Variation in human gut microbiota impacts tamoxifen pharmacokinetics."}],"sample_intervention_arms":{},"sex":{},"title":"Variation in human gut microbiota impacts tamoxifen pharmacokinetics","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1176874","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1176874_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1176874.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1176874.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1176874.csv.gz"}},{"accession":"PRJNA936897","age_categories":{"adult":3},"countries":{"US":3},"first_public_year":"2023","gbp_per_sample_median":0.82,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":3,"papers":[{"doi":"10.3389/fmicb.2023.1148097","pmcid":"PMC10264612","pmid":"37323911","title":"Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples."}],"sample_intervention_arms":{},"sex":{"female":3},"title":"Comparison of Gut Microbiome Composition in Colonic Biopsies, Endoscopically-Collected and At-Home-Collected Stool","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA936897","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA936897_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA936897.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA936897.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA936897.csv.gz"}},{"accession":"PRJNA317435","age_categories":{"adult":2},"countries":{"DE":2},"first_public_year":"2017","gbp_per_sample_median":5.98,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":2},"intervention_design":"observational_with_procedure","intervention_detail":"Allogeneic hematopoietic stem cell transplantation for AML, sampled before/after","interventions":["surgery"],"n_samples":2,"papers":[{"doi":"10.1016/j.trsl.2017.06.008","pmcid":null,"pmid":"28686852","title":"Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation."}],"sample_intervention_arms":{},"sex":{"female":2},"title":"ImMicroDyn","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA317435","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA317435_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA317435.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA317435.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA317435.csv.gz"}},{"accession":"PRJNA771940","age_categories":{"unknown":2},"countries":{"KR":2},"first_public_year":"2022","gbp_per_sample_median":8.45,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":2},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":2,"papers":[{"doi":"10.1038/s41467-024-55388-3","pmcid":"PMC11680825","pmid":"39730328","title":"A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapy."}],"sample_intervention_arms":{},"sex":{},"title":"Uncultivated human gut microbiota modulates immunotherapy response","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA771940","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA771940_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA771940.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA771940.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA771940.csv.gz"}},{"accession":"PRJNA1036657","age_categories":{"adult":1},"countries":{"US":1},"first_public_year":"2026","gbp_per_sample_median":1.16,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":1,"papers":[{"doi":"10.1038/s41522-025-00690-1","pmcid":"PMC12098703","pmid":"40404643","title":"Navigating complexities of polymorphic microbiomes in endometrial cancer."},{"doi":"10.1007/s11136-025-04031-9","pmcid":"PMC12535491","pmid":"40682738","title":"Microbiome impacts quality of life in patients with endometrial cancer and benign gynecological conditions."},{"doi":"10.1128/mra.00961-25","pmcid":"PMC12798068","pmid":"41277863","title":"Draft genome sequence of endometrial <i>Schaalia turicensis</i> strain R31 from a patient with adenomyosis."},{"doi":"10.1128/mra.01234-25","pmcid":"PMC13064086","pmid":"41810936","title":"Draft genome sequence of endometrial <i>Olegusella massiliensis</i> R25 from a patient with adenomyosis."}],"sample_intervention_arms":{},"sex":{},"title":"vaginal, rectal, and endometrial microbiome sequences of women diagnosed with endometrial cancer or benign gynecologic conditions","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1036657","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1036657_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1036657.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1036657.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1036657.csv.gz"}}],"release":"R2026.25"}